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ABSTRACT
The studies comprising this dissertation were designed to investigate the synaptic
organization of norepinephrine and opioid system in the anterior subdivision of the
basolateral nucleus of amygdala (BLa) in rats. Light and electron microscopy were
combined with immunohistochemistry to determine the synaptic incidence and
postsynaptic targets of noradrenergic axon terminals, to localize mu opioid receptors at
the ultrastructural level, and to determine whether there is convergence of norepinephrine
inputs and enkephalin inputs in the BLa. It was determined that about half of the
norepinephrine inputs formed synapses in the BLa and the main postsynaptic targets were
small caliber CAMK+ dendritic shafts and spines of pyramidal cells in the BLa. It was
determined that MOR+ profiles were found in both pre and postsynaptic profiles. The
most frequent labeled structures were small caliber dendrites and terminals. Both
symmetrical and asymmetrical synapses were formed by MOR+ terminals, but the
asymmetrical ones were more commonly observed in the BLa. MOR+ terminals were
mainly targeted spines and small distal dendrites. It was determined that there was very
limited (11%) convergence between ENK+ and norepinephrine terminals. These studies
will contribute to a better understanding of how the noradrenergic and opioid systems
affect BLa neural activity, which is essential to unravel the underlying mechanisms of
memory modulation.
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CHAPTER 1
INTRODUCTION
It is well known that emotionally arousing experiences tend to be well remembered.
Emotional memory consolidation is a well-organized, highly adaptive phenomenon that
helps us to remember important information and thus is critical for our survival
(Roozendaal et al., 2009). Intense or chronic exposure to the stressful events can create
traumatic memories which lead to mood and anxiety disorders such as post-traumatic
stress disorder (PTSD) (Roozendaal et al., 2009, Goodman et al., 2012).
Considerable evidence from animal and human studies has found that the memory
consolidation effects of the amygdala are selectively mediated by the basolateral
amygdala (BLA), especially the anterior basolateral nucleus (BLa) (McGaugh, 2004).
The BLA exerts its memory modulation function via regulating complex interactions
among several neuromodulatory systems (McGaugh, 2004). A large amount of evidence
supports that norepinephrine (NE) serves as a key player, and that the opioid system
could affect memory consolidation by influencing NE release in the BLA (Quirarte et al.,
1998, Ferry and McGaugh, 1999, McGaugh, 2004) . However, the exact circuits of the
NE and opioid system are not clear.
Knowledge of the exact synapses and circuits of NE and opioids is critical for
understanding how they affect each other and thus affect BLA neural activity which is
essential to unraveling the underlying mechanism of memory modulation and identifying
the novel drug targets for related diseases such as PTSD.
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1.1 SIGNIFICANCE OF THE BLA IN MEMORY CONSOLIDATION
The BLA has reciprocal connections with the medial temporal lobe memory
system which consists of the hippocampus and adjacent cortex (Pitkanen et al., 2000) .
The BLA is also the major nucleus in the amygdala projecting to the striatum
(McDonald, 1991, 2003). Through these connections, it modulates memory consolidation
by enhancing striatal-dependent habit memory and modulating hippocampal-dependent
cognitive memory during stress or anxiety situations, which may underlie some aspects
of PTSD symptoms (Goodman et al., 2012). In fact, results from previous studies
suggested that among the numerous nuclei in the amygdala, the BLa is the one selectively
involved in memory consolidation (Tomaz et al., 1992, Parent and McGaugh, 1994, Da
Cunha et al., 1999, McGaugh and Izquierdo, 2000). The exact circuit for memory
consolidation is not clear, but extensive evidence has shown that the influence of the BLa
in the memory consolidation involves interactions of several neuromodulatory systems
including neurotransmitters and stress hormones (McGaugh, 2004). Specifically,
noradrenergic, cholinergic, glucocorticoid and dopaminergic systems have been found to
enhance memory consolidation (Lupien and McEwen, 1997, Hatfield et al., 1999, Power
and McGaugh, 2002, McGaugh, 2004), while GABA and opioid peptides appear to block
the consolidation by inhibiting the effects of the positive modulators (Quirarte et al.,
1998, Hatfield et al., 1999). Taken together, the effects from these different
neuromodulatory systems converge in affecting noradrenergic and muscarinic cholinergic
activation (McGaugh, 2004). Knowledge of the synaptic organization of these
neuromodulatory systems in the amygdala will be critical for understanding the
underlying mechanisms of memory consolidation, and how these circuits may be
disrupted in the disorders of emotional memory, such as PTSD.
2

1.2 NOREPINEPHRINE SYSTEM
The Norepinephrine (NE) system is a widespread system innervating virtually the
entire central nervous system (Berridge and Waterhouse, 2003). Because of its extensive
distribution, the NE system is involved in multiple brain functions, such as attention,
arousal, vigilance, memory, and pain (Berridge and Waterhouse, 2003). Most of the
noradrenergic neurons in the brain are concentrated in the locus ceruleus (LC), which
provides the primary source of the noradrenergic innervation for hippocampus, neocortex
and amygdala (Berridge and Waterhouse, 2003). As a catecholamine, NE along with
dopamine (DA) and epinephrine (E) are sequential products from the same biosynthetic
pathway beginning with dietary tyrosine (Nestler EJ, 2001). Tyrosine is hydroxylated by
the enzyme tyrosine hydroxylase (TH) to form dihydroxyphenylalanine (Dopa). TH is the
rate–limiting enzyme in the catecholamine synthesis. Then Dopa is converted into DA by
an enzyme which also exists in dopamine neurons. DA is converted into NE by the
dopamine-β-hydroxylase (DBH), which is only expressed in NE and E neurons. The
major way of terminating NE function is by reuptake into the neuronal terminal via NE
transporters (NET) (Nestler EJ, 2001). NE is catabolized by monoamine oxidase and
catechol-O-methyltransferase (Nestler EJ, 2001).
NE receptors belong to the G-protein-coupled receptor (GPCR) family and they
can be divided into two types, α and β adrenoceptors, both of which can be further
divided into numerous subtypes with different affinity and response for NE and E
(Nestler EJ, 2001). Among them, all β receptors are Gs-coupled, leading to the activation
of cyclic adenosine monophosphate (cAMP) synthesis and thus triggering the protein
kinase A pathway (Nestler EJ, 2001). Most α1 receptors are Gq-coupled, which trigger
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the phosphatidylinositol cascade and have various effects on neuronal excitability
(Nestler EJ, 2001). α2 receptors are generally coupling with Gi, causing inhibition effects
in most neurons, thus they mainly serve as autoreceptors (Nestler EJ, 2001).
1.3 OPIOID SYSTEM
Endogenous opioid peptides including endorphin, enkephalin (ENK) and
dynorphin are derived from three peptide precursors, proopiomelanocortin, proenkephalin
and prodynorphin, respectively (Stefano et al., 2000, Drolet et al., 2001). As
neuropeptides, endogenous opioids are synthesized in the cell body and then transported
to axon terminals where they are released. Opioids are synthesized as large precursors
(see above) and then undergo complex posttranslational processes (Nestler EJ, 2001).
Unlike small-molecule neurotransmitters such as glutamate and catecholamines, which
are packaged in small synaptic vesicles, opioids are packed in large dense core vesicles.
Similar to other neuropeptides, opioids tend to be released by sustained neuronal activity
and can diffuse a long distance after release.
Endogenous opioid peptides exert their effects via three major types of G-protein
coupled receptors: mu (MOR), delta (DOR) and kappa (KOR), which are coupled to the
Gi/Go family of G proteins (Drolet et al., 2001). Activation of these receptors inhibits
adenylyl cyclase and modulates membrane conductance of calcium and potassium,
leading to inhibitory influences upon neuronal activity (Nestler EJ, 2001). MOR is the
most abundant opioid receptor in the BLA (Mansour et al., 1987, Ding et al., 1996).
Opioid peptides do not bind exclusively to the receptor for which they have highest
affinity. For example, enkephalin has the greatest affinity for DOR, but it also binds to
MOR with high affinity.
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1.4 CLINICAL SIGNIFICANCE OF THE AMYGDALA IN PTSD
Post Traumatic Stress Disorder (PTSD) is an anxiety disorder triggered by
exposure to traumatic experiences such as war, disaster, terrorism, motor vehicle
accidents and violence (Parsons and Ressler, 2013). Although the prevalence of the
PTSD is only 6.8% in the general population, it is much higher (20-40%) for people with
unexpected trauma experience such as crime victims and disaster survivals, or people
with rescue or war-related occupations, for example firefighter, policemen and soldiers
(Javidi and Yadollahie, 2012).Thus, PTSD is the fourth most common psychiatric
diagnosis (Parsons and Ressler, 2013). Around 84% of PTSD patients have comorbid
situations like alcohol and/or drug abuse, major depressive disorder and other anxiety
disorders (Javidi and Yadollahie, 2012).
The amygdala is the major brain area involved in fear-related anxiety disorders
including PTSD (LeDoux, 2000, Goodman et al., 2012, Pitman et al., 2012) . The
findings from neuroimaging studies have shown increased activity of the amygdala in
PTSD patients. (Liberzon et al., 1999, Vermetten et al., 2007, Hughes and Shin, 2011)
Moreover, amygdala activation has been found to positively correlate with PTSD
symptom severity (Rauch et al., 2000, Pissiota et al., 2002, Bryant et al., 2005,
Protopopescu et al., 2005, Dickie et al., 2008, Brunetti et al., 2010) and decreased
amygdala activity is probably related to the resilience to PTSD development after trauma
exposure (Britton et al., 2005, Osuch et al., 2008). The pathological mechanism of PTSD
is not very clear. It is believed that the over-consolidation of traumatic memory due to
dysfunction of amygdala might contribute to its development and persistence (McGaugh,
2004, Goodman et al., 2012, Pitman et al., 2012, Parsons and Ressler, 2013). Better
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understanding of the neuronal circuitry of the amygdala involved in memory
consolidation may help us to further understand PTSD pathology and provide valuable
information for exploring novel treatment or intervention approaches.

6

CHAPTER 2
FUNCTIONAL NEUROANATOMY OF AMYGDALA

The amygdala is an almond-shaped brain nuclear group located in the anteromedial part
of temporal lobe (LeDoux, 2000). It is a heterogeneous structure consisting of several
nuclei, each of which has distinctive neuron types, neurochemical features and
connections (McDonald, 2003). Although the amygdala is a small nuclear complex, it has
extensive connections between its own different nuclei and also with numerous brain
areas (McDonald, 2003). Through these connections, the amygdala produces appropriate
behavioral responses to salient sensory stimuli and emotion arousing events in the
external world and it is a key center for emotional memory (LeDoux, 2000, Millan, 2003,
Sah et al., 2003, McGaugh, 2004). Studies in rats, cats and primates are in close
agreement about the connections of nuclei which are most relevant to fear learning
including the lateral, basolateral and accessory basal nuclei (LeDoux, 2000, McDonald,
2003).
Most of the amygdala nuclei do not have clear borders and the nomenclature for
these nuclei is not consistent among different groups (McDonald, 1998). However, it is
customary to divide the amygdala nuclei into three major groups based on their
anatomical and functional characteristics: the basolateral nuclear group, the cortical
nuclear group and the centromedial nuclear group (McDonald, 2003). Besides, there are
three additional nuclei composing the remaining parts of the amygdala, including, the
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amygdalohippocampal area, the anterior amygdala area, and the intercalated cell nuclei
(ITC) (McDonald, 1998).
2.1 NUCLEI AND CONNECTIONS
2.1.1 BASOLATERAL NUCLEAR GROUP
The basolateral nuclear complex of the amygdala contains three main nuclei:
lateral, basolateral and basomedial nucleus (which are often referred to together as the
basolateral complex (BLC)) (Sah et al., 2003). The BLC receives robust sensory inputs
from the cerebral cortex and thalamus (LeDoux et al., 1984, McDonald, 1998) and it has
reciprocal connections with temporal lobe memory system (Pitkanen et al., 2000). The
BLC also have connections with the basal ganglia and basal forebrain.
The lateral nucleus (LA) is the principle recipient of afferents from sensory
neocortex in the BLC (Pitkanen and Amaral, 1991). It receives dense fibers from
unimodal sensory association area and polysensory processing areas (Romanski et al.,
1993, Romanski and LeDoux, 1993, McDonald and Mascagni, 1997, McDonald, 1998).
Another brain area that projects to the LA is thalamus (LeDoux et al., 1984). In turn, the
LA sends inputs to other amygdalar nuclei including the central, basal and basomedial
nuclei, as well as the hippocampus and parahippocampal cortex (Ottersen, 1982,
Pikkarainen and Pitkanen, 2001). Functionally, the LA is the amygdala region where
conditioned stimuli and unconditioned stimuli are paired during fear conditioning
(Romanski et al., 1993, LeDoux, 2000, Sigurdsson et al., 2007). Therefore it is critical for
fear learning.
Similar to the LA, the basolateral nucleus of the amygdala (BLA) receives
projections from sensory association cortical regions and also projects back to some
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cortical areas (McDonald, 1998). In addition, BLA has reciprocal connections with
insular, cingulated, and prefrontal, and frontal cortex (Beckstead, 1978, Krettek and Price,
1978, Ottersen, 1982, Saper, 1984, McDonald et al., 1996). Other regions giving rise to
afferents to the BLA are the thalamus and hypothalamus. In turn, the BLA sends
projections to the cholinergic basal forebrain and striatum. Moreover, studies suggest that
there are reciprocal connections between the BLA, hippocampus and nearby cerebral
cortex, which provides an anatomical basis for the role of the BLA in emotional memory
consolidation. Hippocampal projections to the BLA and basomedial amygdala appear to
be involved in contextual conditioning (Maren and Fanselow, 1995), whereas cue
conditioning relies more on the lateral nucleus to central nucleus pathway (LeDoux,
2000). The BLA seems to be the major source of intra-amygdaloid innervations,
projecting to central, medial and lateral nuclei (Nitecka et al., 1981, Cassell et al., 1999),
thus it is important for information integration inside the amygdala.
The basomedial nucleus is the major target of the outputs from the lateral nucleus
(Pitkanen and Amaral, 1991, Savander et al., 1997). In addition, it also receives
projections from hypothalamus and brainstem (McDonald, 1998). Through these
connections, the basomedial nucleus plays a role in many autonomic and endocrine
responses related to emotional behaviors (McDonald, 1998). In turn, it sends projections
to the cortical sensory association areas, frontal cortex, and cingulated cortex and
striatum. As mentioned earlier, the basomedial nucleus is involved in contextual
conditioning via its connection with the hippocampus (Maren and Fanselow, 1995).
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2.1.2 CENTRAL MEIDIAL NUCLEAR GROUP
Several nuclei make up the centromedial nuclear group, including the central
nucleus, medial nucleus and intra-amygdaloid proportion of the bed nucleus stria
terminalis (McDonald, 1998). The central and medial nuclei extend forward to become
continuous with the bed nucleus of the stria terminalis. These three structures exhibit
anatomically and functionally similarities and are often collectively referred to as
“extended amygdala” (McDonald, 2003). Nuclei in this group heavily connect with
olfactory, hypothalamus and brain stem, but connect with the cortex and thalamus to a
less extent.
The central nucleus (CeA) is a complex structure and contains four subdivisions
(McDonald, 1982a). The CeA receives extrinsic projections from the insular cortex,
entorhinal cortex, hypothalamus, parabrachial nuclei, nucleus of the solitary tract and
locus ceruleus (Fallon et al., 1978, Ricardo and Koh, 1978, Mason and Fibiger, 1979,
Saper and Loewy, 1980, Ottersen, 1981, Russchen, 1982, Fulwiler and Saper, 1984,
Augustine, 1996, McDonald and Mascagni, 1997). The CeA is also innervated by intraamygdala afferents from other amygdala nuclei including the BLC, intercalated cell
nuclei, cortical and medial nuclei (Cassell et al., 1999, Zimmerman et al., 2007). In turn,
the CeA indirectly projects to the hypothalamus and brainstem via the bed nucleus of the
stria terminalis as a relay site. The CeA also sends substantial inputs to the hypothalamus
directly (LeDoux et al., 1988). In addition, the CeA heavily projects to the brainstem
(Veening et al., 1984). Functionally, CeA serves as an output center important for
mediating fear responses (Samson and Pare, 2005). CeA may also be involved in the
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acquisition and consolidation of fear memory as well (Wilensky et al., 2006, Zimmerman
et al., 2007).
The medial nucleus receives inputs from multiple extrinsic sources including the
piriform cortex, agranular insular cortex, entorhinal cortex, ventral subiculum, and locus
coeruleus (McDonald, 1998, McDonald et al., 1999, Ma and Morilak, 2005).
Additionally, it is also targeted by the BLC (Walker et al., 2005). In turn, the medial
nucleus sends projections to the thalamus, hypothalamus, bed nucleus of the stria
terminalis and brainstem (Canteras et al., 1995). Functionally, the medial nucleus is
crucial for freezing behavior induced by predator odor stimuli (Muller and Fendt, 2006).
The intra-amygdaloid proportion of the bed nucleus stria terminalis (BNST) is
closely related to the stria terminalis (McDonald, 1998). Previous studies have shown that
the BNST is implicated in anxiety behaviors and responses to contextual stimuli (Pego et
al., 2008) (Meloni et al., 2006). Moreover, the BNST is directly involved in the
regulation of the hypothalamus-pituitary-adrenal (HPA) via its projections to the
hypothalamus (Pego et al., 2008). In addition, evidence shows that the BNST may be
activated by less explicit information and thus mediate anxiety, whereas the CeA is
activated by highly processed explicit cue information and therefore involved in
stimulus-specific fear modulation (Davis and Shi, 1999).
2.1.3 CORTICAL NUCLEAR GROUP
The cortical nuclear group includes the cortical nucleus, the nucleus of the lateral
olfactory tract and the periamygdaloid cortex (McDonald, 1998). Nuclei in this group lie
superficially in the amygdala and they extensively connect with the olfactory bulb,
hypothalamus and brain stem, but connect with the cortex and thalamus to a less extent
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(McDonald, 1998). This amygdala nuclear group is heavily involved in olfactory
information processing.
The cortical nucleus has reciprocal connections with the olfactory bulb and it also
receives direct projections from the accessory olfactory bulb and piriform cortex
(McDonald, 1998) (Turner et al 1978, Price 1990, De Olmos et al 1978, Luskin and Price
1983, Post and Mai 1980, Haberly and Price 1978b, Scalia and Winans 1975). In turn, it
sends projections to several cortical areas (Kemppainen et al., 2002, Ubeda-Banon et al.,
2007) (Beckstead 1978, Mufson et al 1981, Saper 1982, McDonald and Jackson 1987)
including the agranular insular cortex, entorhinal cortex and infralimbic prefrontal cortex,
as well as to several subcortical areas such as the hypothalamus and nucleus accumbens,
hippocampus and other amygdala nuclei (Wang and Swann, 2006) (Price et al 1991,
Krettek and Price 1977a,c, Wiegand 1984, Zaborszky 1982, Old and Silv 1985, Ottersen
1980, Berk and Finkelstein 1982, Conrad and Pfaff 1976a and b, Krieger et al 1979,
Swanson 1976, Saunders 1988). Functionally, previous study suggests that the cortical
nucleus is important for odor learning and olfactory fear conditioning (Sevelinges et al.,
2004).
The nucleus of the lateral olfactory tract (NLOT) consists of three layers
(McDonald, 1983). The NLOT has reciprocal connections with the olfactory bulb and
piriform cortex (Schwob and Price, 1984, McDonald, 1998). The NLOT also send
projections to the anterior olfactory nucleus, the olfactory tubercle, BLC, nuclear
accumbens, caudate putamen and agranular insular cortex (Santiago and ShammahLagnado, 2004). Functionally, this amygdalar nucleus may influence nonpheromonal
olfactory guided behaviors such as feeding (Santiago and Shammah-Lagnado, 2004).
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The periamygdaloid cortex extensively interconnected with the olfactory bulb and
piriform cortex (McDonald, 1998). This structure also projects to the hippocampus and
parahippocampal regions, as well as other amygdalar nuclei including the BLC, cortical,
and medial nuclei (Majak and Pitkanen, 2003). Functionally, it is an amygdaloid region
processing olfactory information. Moreover, its connections with hippocampus may
allow emotional significant olfactory stimuli to enter the medial temporal lobe memory
system (Majak and Pitkanen, 2003).
2.1.4 OTHER NUCLEI
The remaining amygdala contains three additional nuclei. They are the
amygdalohippocampal area, the anterior amygdaloid area, and the intercalated cell nuclei
(ITC).
The amygdalohippocampal area receives projections from the hippocampus
(Kishi et al., 2006). It provides the most substantial amygdala inputs to the endopiriform
nucleus and sends a light projection to the claustrum (Majak et al., 2002).
The anterior amygdaloid area lies at the rostral pole of the amygdala and is
diffusely organized (McDonald, 1998). This area is possibly involved in modulation of
attention (Gastard et al., 2002).
The ITC is made up of a group of cells which are predominantly inhibitory
(McDonald and Augustine, 1993). The ITC receives intrinsic projections from the BLC
and extrinsic projections from the infralimbic PFC and hippocampus (McDonald et al.,
1996, Royer et al., 1999, Kishi et al., 2006). In turn, it sends projections to the central and
medial nuclei, and basal forebrain (Pare and Smith, 1993, Smith and Pare, 1994).
Functionally, the ITC serves as a critical modulator for the communication among
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amygdala nuclei, as well as between amygdala and subcortical regions (Royer et al.,
1999). Evidence also indicates that ITC may be important for the extinction of fearrelated memory (Royer et al., 1999).
2.2 NEURONAL MORPHOLOGY AND PHENOTYPE OF THE BLA
There are two major cell types in the BLA, pyramidal and nonpyramidal neurons
(also referred to as class I and II neurons, respectively) (McDonald, 1982b). Pyramidal
neurons represent the predominant cell type in the BLC and constitute about 85% of the
total neuronal population in this region. These neurons contain glutamate and/or aspartate,
the principle excitatory neurotransmitters in the mammalian brain. Golgi stains show that
pyramidal neurons are large, spiny neurons that vary in size in different subdivisions of
the BLC (McDonald, 1982b). These neurons often have a large pyramidal shaped cell
bodies and dendrites with dense spines (McDonald, 1982b). Pyramidal neurons are
projection neurons and their axons usually give rise to several collaterals which arborize
modestly in the vicinity of the cell body (McDonald, 1982b, 1992).
Golgi stains reveal that nonpyramidal neurons are smaller neurons compared with
pyramidal neurons and they are morphologically heterogeneous (McDonald, 1982b,
1985a). Nonpyramidal neurons are interneurons and characterized by spine-sparse
dendrites and axons with fairly dense local arborizations. Immunohistochemistry study
reveals that the majority of nonpyramidal neurons contain gamma aminobutyric acid
(GABA) (McDonald, 1985a), a major inhibitory neurotransmitter in the mammalian
central nervous system. They can be distinguished based upon their content of various
neuropeptides (McDonald, 1985b, McDonald and Pearson, 1989), including somatostatin
(SOM), vasoactive intestinal peptide (VIP), cholecystokinin (CCK), neuropeptide Y
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(NPY), as well as their content of calcium binding proteins (McDonald, 1994a, 1997,
McDonald and Betette, 2001, McDonald and Mascagni, 2001, Mascagni and McDonald,
2003), including parvalbumin (PV), calbindin (CB) and calritinin (CR). Because there are
significant overlaps among these different types of nonpyramidal neurons in the BLC,
they can be further grouped into four distinct subpopulations (Mascagni and McDonald,
2003) 1) PV+ neurons (most of them contain CB); 2) SOM+ neurons (many of them are
CB+ and NPY+ ); 3) large CCK+ neurons (some of them are CB+) and 4) small bipolar
neurons that exhibit various amount of colocalization of VIP, CR and CCK.
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CHAPTER 3
NORADRENERGIC INNERVATION OF PYRAMIDAL CELLS IN THE RAT
BASOLATERAL AMYGDALA

3.1 INTRODUCTION
The basolateral amygdalar nuclear complex (BLC) receives a dense noradrenergic input
primarily originating from the locus coeruleus (LC) (Asan, 1998), which is heavily
involved in stress and stress-related pathologies (Sved et al., 2002). Studies have shown
that stressful stimuli such as foot shock induce norepinephrine (NE) release in the rat
amygdala (Galvez et al., 1996, Quirarte et al., 1998). Also, human functional magnetic
resonance imaging (fMRI) studies show that elevated NE neurotransmission enhances
BLC responses to fear signals (Onur et al., 2009). Moreover, a large amount of evidence
(Cahill et al., 1995, Ferry and McGaugh, 1999, McGaugh, 2004, Ferry and McGaugh,
2008, Roozendaal et al., 2009) indicates that the NE system in the BLC is involved in
memory modulation by stress (Cahill et al., 1995, Ferry and McGaugh, 1999, McIntyre et
al., 2002, McGaugh, 2004, Ferry and McGaugh, 2008, Roozendaal et al., 2009).
Therefore, the LC is important for providing information about aversive stimuli to the
BLC and generating appropriate responses to stressors, which suggests that the LC-NE
circuit in the BLC could be a potential drug target for anxiety disorders.
Although there is abundant behavioral and clinical evidence for the role of the NE
system of the BLC in stress and anxiety, there is still no clear picture about how NE
affects the activity of BLC neurons. Recent studies reveal that BLC neurons can be
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inhibited or excited by NE afferents from the LC (Buffalari and Grace, 2007, Chen and
Sara, 2007), but in many cases it was difficult to determine whether the recorded neurons
were pyramidal cells or interneurons based on their electrophysiological properties
(Buffalari and Grace, 2007, Chen and Sara, 2007, Buffalari and Grace, 2009). Therefore,
there is still considerable confusion regarding the differential modulation of distinct
neuronal subpopulations in the BLC by the NE.
Anatomical knowledge of NE circuits in the BLC should help to clarify the
uncertainties of the physiological studies. A previous study using dopamine-βhydroxylase (DBH) as a marker for NE axons suggested that only 11% of DBH+
terminals in the BLC form synapses (Asan, 1998). This suggests that the NE innervation
of the BLC is mainly mediated by non-junctional, diffuse release of NE into the
extracellular space. However, a later study indicated that approximately 31% of DBH+
terminals in the lateral amygdala (LA) form synaptic junctions (Farb et al., 2010). This
discrepancy may be the result of different criteria for synapse identification or the
nucleus studied. Because these studies analyzed single thin sections, rather than doing
serial section analysis of synapses, it seems likely that the synaptic incidence may be
higher than 31%.
Previous electron microscopy studies have shown that the major postsynaptic
targets of DBH+ terminals were dendritic shafts and spines, but the cell types of origin of
these structures were not identified (Asan, 1998, Farb et al., 2010). Although it has been
reported that 4% of DBH + terminals formed synapses with GABA+ neuronal structures,
presumably interneurons, another study from the same group also indicate that 30% of
DBH+ terminals contacted interneurons which exhibit choline acetyltransferase
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immunoreactivity (Li et al., 2001). These inconsistent results suggest that it is still not
clear about the extent that NE terminals synapse with pyramidal neurons and interneurons
in the BLC.
The purpose of the study in this chapter was to determine the synaptic incidence
and postsynaptic targets of NE axon terminals in the anterior subdivision of the
basolateral nucleus of the amygdala (BLa), the main nucleus responsible for NEmediated memory consolidation (McGaugh, 2004). An antibody to the norepinephrine
transporter (NET) protein was used to label NE axons since a previous study of this
nucleus found that visualization of DBH immunoreactivity at the ultrastructural level
required immunohistochemistry procedure that hindered morphological preservation of
neuronal processes and synapses (Asan, 1998). This is the first EM study of the amygdala
to use NET as a marker for noradrenergic axons. An antibody to the alpha subunit of
calcium/calmodulin kinase ǁ (CaMK ǁ) was used to selectively label pyramidal cells
(McDonald et al., 2002) in these dual-labeling studies. To obtain a more precise
estimation of the synaptic incidence of the NE innervations of the BLa, a serial section
analysis of NET+ terminals and their contacts was performed.
3.2 HYPOTHESIS
Most NE axon terminals will not form synapses in the BLa and if the NE axon
terminals form synapses then their major postsynaptic targets in the BLa will be distal
dendritic shafts and spines.
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3.3 METHODS
3.3.1 TISSUE PREPARATION
Male Sprague-Dawley rats weighing 250-350g were used in these experiments.
Rats were handled in accordance with the principles of laboratory animal care and
protocols approved by the University of South Carolina Institutional Animal Care and
Use Committee. Brain tissue was prepared as described in previous studies of our lab
(Muller et al., 2011). For light microscopy, rats were anesthetized with chloral hydrate
(350 mg/kg) and perfused intracardially with phosphate buffered saline (PBS; pH 7.4)
containing 0.5% sodium nitrite (50ml) followed by 4% paraformaldehyde in phosphate
buffer (PB; pH 7.4) for 20 mins. Then brains were removed and post-fixed in the
perfusate for three hours. For electron microscopy, rats were anesthetized and perfused
intracardially with PBS containing 0.5% sodium nitrite (50ml) followed by 2%
paraformaldehyde-3.75% acrolein in PB for 1min, followed by 2% paraformaldehyde in
PB for 3 mins. Brains were removed and post-fixed in 2% paraformaldehyde for 1 hr.
Brains were sectioned on a vibratome in the coronal plane at 50μm.
3.3.2 LIGHT MICROSCOPY IMMUNOHISTOCHEMISTRY
Single-label localization of NET+ fibers was performed in two rats using a rabbit
antibody to NET (1:2000, antibody 43411, obtained from Dr. Randy D. Blakely,
Vanderbilt University Medical Center). All antibodies were diluted in PBS containing
0.4% Triton X-100 and 1% normal goat serum. Sections were incubated in the primary
antibody overnight at 4℃ and then processed for the avidin-biotin immunoperoxidase
technique using a biotinylated goat anti-rabbit secondary antibody (1: 500, Jackson
Immunoresearch Laboratories, West Grove, PA) and a Vectastain standard ABC kit
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(Vector laboratories, Burlingame, CA) with nickel-intensified 3,3-́diaminobenzidine
4HCl (DAB, Sigma Chemical Co., St. Louis, MO, USA) as a chromogen to generate a
black reaction product (Hancock, 1986). After the reactions, sections were mounted on
gelatinized slides, dried overnight, dehydrated in ethanol, cleared in xylene, and
coverslipped in Permount (Fisher Scientific, Pittsburgh, PA, USA). Sections were
analyzed with a Nikon E600 microscopy system and digital light micrographs were taken
with a Micropublisher digital camera.
3.3.3 DUAL IMMUNOFLUORESCENCE IMMUNOHISTOCHEMISTRY
Dual localization studies were performed in two rats using the rabbit NET
antibody (1:1000; see above) and a mouse monoclonal antibody to dopamine-betahydroxylase (DBH, 1:600; clone 4F10.2, catalog #MAB308, Chemicon International
Inc.), the synthetic enzyme for norepinephrine, to determine the overlapping extent of
NET immunoreactivity and DBH immunoreactivity in the BLa. Sections were incubated
in PBS containing 0.4% Triton X-100 and 1% normal goat serum at room temperature for
two hours, and incubated overnight at room temperature in a cocktail of the rabbit NET
antibody and the mouse monoclonal DBH antibody. After incubation in the primary
antibody cocktail, sections were rinsed in PBS and incubated in a cocktail of goat antirabbit Alexa-488 and goat anti-mouse Alexa-543 labeled secondary antibodies (1:400;
Invitrogen, Grand Island, NY, USA) for 3h at room temperature. All secondary
antibodies were highly cross-adsorbed by the manufacturer to ensure specificity for
primary antibodies raised in the particular species. Sections were then rinsed in PBS and
mounted on glass slides using Vectashield mounting medium (Vector Laboratories).
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Sections were examined with a Zeiss LSM 510 Meta microscope. Fluoresence of
Alexa 488 (green) and Alexa 543 (red) dyes was analyzed using filter configurations for
sequential excitation via 488nm and 543nm channels. Digital images were adjusted for
brightness and contrast using Photoshop 6.0 software. Control sections were processed
with one of the two primary antibodies omitted and only the color of the corresponding
secondary fluorescent antibody was observed on the appropriate channel in these
sections. These results indicated that the secondary antibodies were specific for rabbit or
mouse IgG and that there was no “crosstalk” between the red and green channels
(Wouterlood et al., 1998).
3.3.4 ELECTRON MICROSCOPY DOUBLE LABELING
IMMUNOHISTOCHEMISTRY
For electron microscopy studies, a sequential dual-labeling immunoperoxidase
method was used in three rats to observe the NE innervation of pyramidal cells in the
anterior subdivision of the basolateral nucleus of the amygdala (BLa) (bregma level -2.1
through -3.0) (Paxinos and Watson, 1986). To enhance penetration of antibodies, sections
were either subjected to a freeze-thaw procedure or were incubated with low levels of
Triton-X-100 (0.02-0.04%) in the antibody solutions. For freeze-thaw, sections were
crypoprotected in 30% sucrose in PB for 3 hours, followed by three cycles of freezingthawing over liquid nitrogen to facilitate antibody penetration. Sections were then rinsed
in PB and incubated in a blocking solution (PBS containing 3% normal goat serum and
1% BSA) for 30 mins at room temperature. All antibodies were diluted in the blocking
solution. Sections were incubated in the rabbit antibody to NET (1:2000) overnight at 4℃
and then processed using a biotinylated goat anti-rabbit second antibody for one hour
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(Jackson Immunoresearch Laboratories, West Grove, PA) and a Vectastain standard ABC
kit (Vector laboratories, Burlingame, CA) with DAB as the chromogen. After rinsing,
sections were incubated in an avidin/biotin blocking solution (Vector Laboratories,
Burlingame, CA). Sections were then incubated overnight at 4℃ in mouse anti-CaMK
antibody (1:500; Sigma) to label pyramidal cells. For CaMK immunoreactivity, sections
were processed using a biotinylated goat anti-mouse secondary antibody (1:200, Jackson
Immunoresearch Laboratories) and an Elite ABC kit (Vector Laboratories). CaMK
immunoreactivity was then visualized by using a Vector-VIP (Very Intense Purple)
peroxidase substrate kit (V-VIP, Vector laboratories). This step produces a reaction
product that appears purple in the light microscope and granular in the electron
microscope, which was easily distinguishable from the diffuse DAB immunoperoxidase
reaction product.
3.3.5 PROCEDURE FOR ELECTRON MICROSCOPY
After the immunocytochemical reactions, sections were post-fixed in 2% osmium
tetroxide in 0.16 M sodium cacodylate buffer (pH=7.4) for 1 hour, dehydrated in ethanol
and acetone, and then flat embedded in Polybed 812 (Polysciences, Warrington, PA) in
slide molds between sheets of Aclar (Ted Pella, Redding, CA). Selected areas of the BLa
were remounted onto resin blanks. Silver thin sections were collected on formvar-coated
slot grids, stained with uranyl acetate and lead citrate, and examined with a JEOL-200CX
electron microscope. Micrographs were taken with an AMT XR40 digital camera system
(Advanced Microscopy Techniques, Danvers, MA)
3.3.6 ANALYSIS
Two 50μm vibratome sections from each animal were analyzed. From these sections,
areas with robust presence of both labels were chosen for quantitative analysis. NET+ terminals
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were followed and fully or partially reconstructed in 3 to 13 serial thin sections. Serial sections
were helpful for verifying labels in small and/or lightly immunoreactive structures, and for
determining synaptic contacts. NET+ varicosities were considered to form synapses if they
showed the following characteristics: 1) parallel presynaptic and postsynaptic membranes
exhibiting membrane thickening, 2) clustered vesicles associated with the presynaptic membrane,
and 3) a synaptic cleft containing dense material. Postsynaptic neuronal profiles receiving
synapses from NET+ varicosities were identified as somata, large caliber dendritic shafts
(diameter >1µm), small caliber dendritic shafts (diameter <1µm), and spines according to
established morphological criteria (Peters A, 1991). Although CaMK is a reliable marker for
pyramidal cells and their processes in the BLa, many spines of the pyramidal cells do not exhibit
CaMK immunoreactivity (McDonald et al., 2002). However, since the results of previous studies
suggest that the great majority of spines observed in electron microscopy studies belong to
pyramidal cells (Muller et al., 2006), all spines, whether CaMK + or not, were considered to be of
pyramidal cell origin. Some NET+ terminals contacted glial cell processes. These glia cell
processes were identified by their irregular shape and their tendency to fill the space between
neuronal structures.

3.3.7 ANTIBODY SPECIFICITY
The NET antibody we used was obtained from the cytoplasmic NET epitope
(amino acids 585-602). Previous study (Schroeter et al., 2000) has shown that this NET
antibody labeling confined to NE neuronal somata, axons and dendrites, but absent from
adrenergic and dopaminergic neurons. It recognizes a single 80-kDa band corresponding
to the mature N-glycosylated NET protein in western blot of brain samples. Preadsorption with the peptide eliminates immunoblots and immunostaining of tissue
sections. Additionally, its specificity was validated by the toxin treatment which destroys
most of NE neurons. Meanwhile, CaMK antibody has been reported to be a reliable
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marker for pyramidal cell perikarya and dendrites (McDonald and Mascagni, 2002). The
specificity of CaMK antibody has been well documented in previous studies and it
recognizes both phosphorylated and nonphosphorylated forms of the kinase (McDonald
et al., 2002). Therefore, we use this NET and CaMK antibodies to find out how
noradrenergic inputs synapse with pyramidal cells.
3.4 RESULTS
3.4.1 LIGHT MICROSCOPY OBSERVATIONS
NET+ axons were distributed across the basolateral nuclear complex of the
amygdala (BLC). NET+ axons were denser in the BLa than in the lateral and central
nuclei (Figure 3.1.A). NET+ axons had small or large varicosities with relatively short
inter-varicose segments and ran in all directions (Figure 3.1.B). Dual localization
experiments of NET and DBH revealed that almost all axons were dual-labeled (Figure
3.2). However, there were few varicosities that were DBH positive but NET negative,
and some inter-varicose segments were NET positive but DBH negative (Figure 3.2.C).
3.4.2 ELECTRON MICROSCOPY OBERSERVATIONS
At the electron microscopy level, NET+ profiles consisted of thin unmyelinated
axons and varicosities containing synaptic vesicles (Figures 3.3-3.5, 3.7-3.9). The
peroxidase reaction product was distributed throughout these NET + profiles, with
accumulations near the plasma membrane and the outer membrane of vesicles and
mitochondria. NET+ terminals were round or ovoid, with closely packed small, round
clear synaptic vesicles, sometimes associated with large clear vesicles (Figures 3.3-3.5,
3.7-3.9). Occasional medium size, dense-core vesicles were also seen (Figures 3.3.B and
3.7). These terminals ranged in size from 0.16 to 1.3 µm in diameter and some of them
contained one or more mitochondria. The morphology of NET+ profiles was consistent
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with descriptions of DBH+ profiles reported in previous studies of the basolateral
amygdala. (Asan, 1998, Li et al., 2001, Li et al., 2002, Farb et al., 2010).
NET+ terminals formed synapses with both CaMK+ and unlabeled profiles in our
dual-labeling preparations, and their postsynaptic targets include somata, large and small
caliber dendrites, and spines (Figures 3.3-3.6) (Table 3.1). No direct contact with
endothelial cells was observed, but in one case, a small NET terminal apposed a glial
process which surrounded a blood vessel. The synaptic incidence of NET+ terminals was
determined by examining each terminal in 3 to 13 serial thin sections, averaging 6.5 ±2.3
(Mean ±SD). The average number of serial sections used to reconstruct terminals
forming synapses (6.6 ± 2.4) was virtually identical to the non-synaptic terminals (6.5 ±
2.3). Terminals which lacked distinct contours or occurred in too few available sections
to identify synapse formation were excluded from the analysis. About half (45/98 or
46%) of NET+ terminals formed synapses. The size of terminals forming synapses
ranged from 0.2 - 0.96 µm in diameter, averaging 0.45 ±0.19 µm (Mean ±SD).
Terminals which did not form synapses ranged in size from 0.16 to 1.28 µm in diameter,
averaging 0.61 ±0.25 µm. Both symmetrical and asymmetrical synapses were observed,
but symmetrical synapses were more common (38/45 or 84%) (Table 3.1).
Most (38/45 or 84%) of the synapses were formed with pyramidal cells (CaMK+
structures and spines) (Figures 3.3-3.5) (Table 3.1). The main postsynaptic target were
small dendritic shafts (15/38 or 39%) (Figures 3.3.A, 3.3.B and 3.5.C) and spines (14/38
or 37%) (Figures 3.4 and 3.5.D). However, some also occurred on large dendritic shafts
(8/38 or 21%) (Figures 3.3.C and 3.3.D), and one symmetrical synapse was found on a
CaMK+ soma (Figures 3.5.A and 3.5.B). Synapses formed with unlabeled neuronal
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processes, presumably interneurons, mainly targeted small dendritic shafts (Figure 3.7).
In two instances, NET+ axons appeared to encapsulate an unlabeled axon terminal and its
postsynaptic spine (Figures 3.8 and 3.9). In additional to the neuronal profiles, some
NET+ terminals (7/98 or 7.1%) formed apposition with astrocytic processes that
sometimes had characteristics of synapses (Figure 3.10).
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Figure 3.1 NET immunoreactivity in the BLa. A, Lower power
immunofluorescence micrograph illustrating NET+ fibers (green) in the BLa, La
(lateral nucleus) and CL (later subdivision of central nucleus) at bregma level -2.1.
B, High power micrograph illustrating NET+ fiber morphology in the BLa using
nickel-enhanced DAB as a chromogen in an immunoperoxidase preparation.
Arrows point to the NET+ varicosities. Scale bar=100μm in A, 10μm in B
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Figure 3.2 NET and DBH immunoreactivity in the BLa. A1-A3: Lower
power immunofluorescence micrographs. ( A1) Green channel
micrograph showing NET antibody labeled axons in the BLa. (A2) Red
channel micrograph showing DBH antibody labeled axons in the same
field as A1. (A3) Merged image showing dual localization of NET and
DBH in yellow. Virtually all axons are double-labeled. B1-B3: Higher
magnification Z series reconstruction (1μm between optical sections for
12 sections) NET and DBH immunoreactivity in the BLa. (B1) NET
(green) in the BLa. (B2) DBH (red) in the same field as B1. (B3)
Merged image showing co-localization of NET and DBH in yellow.
Virtually all axons are double-labeled (yellow). Arrows point to an
axon segment which is enlarged in C. C: High power Z series
reconstruction of an axon segment shown in B3. Double-labeled
structure showing yellow. Scale bar=50μm in A1-3, 10μm in B1-3,
1μm in C
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Figure 3.3 NET+ terminals innervate CaMK+ dendrites. A and B: NET terminals
(Nt) form symmetrical synapses (arrows) with small caliber (<1 μm) CaMK+
pyramidal cell dendrites (Cd). The NET+ terminal in B contains two small dense
core vesicles (small arrows). C and D: NET terminals (Nt) form symmetrical
synapses (arrow) with large caliber (≥1 μm) CaMK+ pyramidal cell dendrites (Cd).
Arrowheads indicate the particulate V-VIP label for CaMK. Scale bar=0.5μm.
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Figure 3.4 NET+ terminals innervate CaMK+ spines. A and B: Two adjacent thin
sections through three NET+ terminals (Nt1-3) which form symmetrical (Nt2 in A
and Nt3 in B) and asymmetrical (Nt 1 in A) synapses (arrow) with spines (sp).
Arrowheads indicate the particulate V-VIP labels for CaMK. A and B are the 2nd and
3rd sections, respectively, from a 6-section series. Scale bar=0.5μm.
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Figure 3.5 An NET+ axon forms multiple contacts with a CaMK+ pyramidal cell
soma and adjacent CaMK+ dendritic processes. A: Low power micrograph showing
two terminals (Nt1 and Nt2) of a single NET+ axon form symmetrical synapses
(arrows) with a CaMK + dendrite (left) and a CaMK+ soma (right, Cs) B-D: High
power micrograph showing three sections in a serial passing through the axon shown
in A (C corresponds to the section shown in A). (B) Nt2 forms a symmetrical synapse
(arrows) with a CaMK+ soma (Cs, also seen in C). (C) Nt1 forms a synapse (arrows)
with a CaMK+ dendrite. This synapse appears symmetrical in this section, but
appears to be associated with postsynaptic density in B. (D) Nt2 surrounds and forms
a symmetrical synapse (arrow) with a spine (Sp, right) which is extending from a
CaMK+ dendrite (Cd). Nt1 form a symmetrical synapse with another spine (Sp, left).
Arrowheads indicate the particulate V-VIP labels for CaMK. B-D are the 12th, 10th
and 8th sections, respectively, from a 12-section series. Scale bar=0.5μm.
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Table 3.1 Postsynaptic Targets of NET + terminals in the BLa in preparations dual
labeled for NET and CaMK.
Postsynaptic
Targets

+S

+LD

+SD

Sp

-S

-LD

-SD

Symmetrical
NET synapses

1
3%

7
18%

13
34%

12
32%

1
3%

0
0

4
10%

Asymmetrical
NET synapses

0
0

1
14%

2
29%

2
29%

0
0

1
14%

1
14%

Total Number
of NET
synapses

1

8

15

14

1

1

5

Total
Number
38
100%
7
100%
45

2%

18%

34%

31%

2%

2%

11%

100%

Note: +: CaMK labeled; -: unlabeled; S, soma; LD, large dendrite (diameter ≥1µm);
SD, small dendrite (diameter <1µm); Sp, spine. n=98.
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Postsynaptic Targets of NET+
Terminals in the BLa
Numbers of Synapses Formed
by NET+ Terminals

25
20
15

Spines

10

CaMK-negative postsynaptic
structures

5

CaMK-positive postsynaptic
structures

0

Soma

Large
Small
Dendrite Dendrite

Spine

Figure 3.6 Histogram showing the number of synapses of NET+ terminals
with CaMK positive (dark gray) or negative (light gray) and spines (white)
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Figure 3.7 A NET+ terminal innervates an unlabeled dendrite. A
NET+ terminal (Nt) forms an asymmetrical synapse (arrows) with
an unlabeled dendrite (Ud). Arrowheads indicate the particulate
V-VIP label for CaMK. Small arrows show the dense core
vesicles. Scale bar=0.5μm.
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Figure 3.8 A NET+ terminal surrounds a synaptic structure. A-D: Four
sections in sequential order from serial thin sections through an NET+
terminal (Nt) that envelopes a synapse formed by an unlabeled terminal
(Ut) and its postsynaptic spine (Sp). The NET terminal (Nt) appears to
form a synapse with the spine (Sp) in B. A-D are the 1st, 4th,8th, and 12th
sections, respectively, from a 13-section series. Scale bar=0.5μm.
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Figure 3.9 A NET terminal surrounds a synaptic structure. A-D: Four sections in
sequential order from a series of sections through an NET+ axon terminal (Nt) that
envelops a synapse formed by an unlabeled axon terminal (Ut) and its postsynaptic
spine (Sp). The NET terminal appears to form a synapse with the spine in B (arrow).
A-D are the 2nd, 6th, 8th and 12th sections, respectively, from a 12 section series. Scale
bar=0.5μm.
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Figure 3.10 NET+ terminals contact with astrocytic processes. A and B: NET+
terminals (Nt) form synapse like contacts with astrocytic processes (G); Scale
bar=0.5μm.
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3.5 DISCUSSION
This is the first study to use NET as a marker for NE fibers in the amygdala. The
distribution of NET immunoreactivity is consistent with observations of nisoxetine
autoradiographic labeling of NET in the amygdala (Hipolide et al., 2005, Smith and
Porrino, 2008). At both light and electron microscopy levels, the morphology of NET+
fibers in our investigation seems to be identical to that described in previous studies of
cortex using the same antibody as a NE axon marker (Miner et al., 2003). Our dual
labeling light microscopy results revealed that DBH was more concentrated in terminals,
and NET tends to localize in the axons and terminals, but their staining mostly
overlapped in the BLa. This is the first NE study in the BLa using CaMK
immunohistochemistry to identify pyramidal cells. In addition, it is also the first NE
study conducting serial section analysis, which should provide a relatively precise
estimate of synaptic incidence. According to our observations, only half of the NET+
terminals form synapses in the BLa and the most frequent targets of these terminals are
smaller dendritic shafts and spines of pyramidal cells.
3.5.1 ANATOMICAL CONSIDERATIONS
A previous study using DBH as a marker for NE axons suggested that 11% of
DBH+ terminals in the basolateral complex of the amygdala formed synapses (Asan,
1998). However, a later study suggested that approximately 31% of DBH terminals in the
LA formed synaptic junctions (Farb et al., 2010). The discrepancy may represent
differences in synapse identification criteria, experimental methods, or the nucleus
studied. A stronger fixation (acrolein) may have contributed to the higher synapse
incidence in Farb’s results. We used acrolein in our study, but the higher (46%) synaptic
incidence is most likely due to the analysis of serial sections. However, only some of the
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NET+ terminals were completely followed during our observation since the average
analyzed distance (average section numbers for analysis × section thickness =0.42 μm) is
less than the average size of NET+ axon terminal (0.52 μm). It is possible that we missed
some of the synaptic formations. Moreover, if the plane of section is not favor for the
synapses, we might also miss them. It seems that the actual synaptic incidence of NE in
the BLa may be higher than 46%.
However, this number (46% or even higher) is still much lower than the synaptic
incidence of other neurotransmitters in previous BLa studies of our lab, such as serotonin
(76%), dopamine (77%) and acetylcholine (76%), which used the same technique and
analysis strategy (Muller et al., 2007, 2009, Muller et al., 2013). This indicates that the
NE system is unique in the BLa. This suggests that NE axons in the BLa function partly
by non-junctional, diffuse release of NE in the extracellular space.
There are similar disagreements about noradrenergic synaptic incidence in the rat
cortex. An early study using DBH immunohistochemistry revealed that more than half of
the DBH-positive varicosities form synapses in the central nervous system (Olschowka et
al., 1981) and the vast majority of noradrenergic projections form synapses in the visual
and frontoparietal cortex (Papadopoulos et al., 1989). Later studies suggested that only
15-20% of NE terminals form synapses in neocortex and hippocampus (Seguela et al.,
1990, Umbriaco et al., 1995). However, a recent study reported a higher percentage
(24%) of synapse formation in the prefrontal cortex using NET as a marker for NE axons.
(Miner et al., 2003). These differences in synaptic incidence appear to be due to
differences in criteria for synapse identification, fixation, cortical area studied, and the
extent of serial section analysis.
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Consistent with previous investigations in the amygdala, NET+ terminals mainly
synapsed with dendrites and spines; very few were seen with somata. Our double labeling
preparations revealed that CaMK+ smaller dendrites and spines were the most frequent
postsynaptic targets of noradrenergic system in BLa. Thus, the synaptic modulation of the
BLA by NE afferents from LC would appear to be mediated primarily by inputs to the
distal dendrites of pyramidal cells.
It has been reported that 4.4% of DBH+ terminals form synapses with dendrites
of GABA+ interneurons in BLa (Li et al., 2002). We observed a higher rate of synapse
formation (16%) with unlabeled neuronal structures, (i.e., presumptive interneurons), but
it is possible that some of these unlabeled structures were false negatives. Li and
colleagues only observed asymmetrical synapses with interneurons, but we found that
NET+ terminals also formed symmetrical synapses with unlabeled dendrites.
Although both symmetrical and asymmetrical synapses were found in our
preparations, NET+ terminals predominantly formed symmetrical synapses with both
labeled and unlabeled structures, which is consistent with previous reports (Asan, 1998,
Farb et al., 2010). Since symmetrical synapses are typically inhibitory and the
asymmetrical ones are excitatory, the general effect of NE inputs on the BLa neurons
possibly is inhibitory. But, this assumption is based on the glutamate and GABA systems;
it may not be true if applying to other neurotransmitter systems, like NE. For example,
almost all cholinergic synapses in the BLa are symmetrical, but acetylcholine mainly has
excitatory effects on BLa neurons (Muller et al., 2011). The presence of symmetrical or
asymmetrical synapses may represent different types of receptors. Previous studies have
found that there are several different subtypes of alpha and beta adrenergic receptors
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expressed in BLa neurons. For example, Farb reported that β-adrenergic receptors are
present in pyramidal and interneuron cell bodies, dendritic shafts and spines in the LA
(Farb et al., 2010). An earlier study revealed that NE directly excited interneurons via the
α1 adrenergic receptor in BLa (Kaneko et al., 2008).
Interestingly, we observed that two NET+ terminals send out sheet-like
extensions that envelope an unlabeled terminal and its postsynaptic spine. Both of these
NET+ terminals appeared to form symmetrical synapse with the spine. This unique
structure has also been seen in the frontal cortex ((Seguela et al., 1990). However, it is
not clear about the functional significance of this kind of configuration. This NET+
enclosure may isolate the unlabeled synapses from surrounding structures and thus make
it only under NE control.
We observed some synapse-like appositions of NET+ terminals with astrocytic
processes suggesting neuronal-glial interactions. This finding is consistent with previous
observations of the astrocytic localization of β-adrenergic receptors in rat brain (Aoki,
1992, Farb et al., 2010).
3.5.2 FUNCTIONAL IMPLICATIONS
Considering that only about half of NET+ terminals form synapses in the BLa,
non-junctional, diffuse release of NE into the extracellular space could be involved in NE
modulation of BLa functions. This intercellular communication mode, called volume
transmission (VT), was first introduced by Agnati and Fuxe (Agnati et al., 1986). Unlike
traditional junctional or wired transmission (WT), VT lacks any wire-like channel
connecting signal sources and targets. VT utilizes the same set of neurotransmitters and
receptors as WT, but VT signals can be released from axons without synaptic membrane
specialization, and they could diffuse in the extracellular space for a long distance
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(Agnati et al., 2010). VT is principally responsible for the tonic control of brain function
through extrasynaptic receptors, and most CNS drugs primarily affect VT instead of WT
(Vizi et al., 2010).
Moreover, unlabeled terminals were found in the vicinity of some NET+
terminals including the sheet-like structures mentioned earlier, but they don’t have
synaptic contact with NET+ terminals. This finding suggests that presynaptic effects of
NE on BLa neuronal circuit may come from NE released from non-synaptic junctions by
VT or spillover from synaptic terminals (Huang et al., 1996, Ferry et al., 1997, Braga et
al., 2004).
LC neurons fire in two distinct activity modes: tonic and phasic (Berridge and
Waterhouse, 2003). The synaptic formations we observed in the present study seem to
contribute to the NE release in the BLa during the phasic mode activity of the LC in
response to salient sensory stimuli like footshock as well as direct electrical stimulation
of the LC in vivo since the response of the BLa neuron has a relative short latency and a
temporal relationship with the excitation of LC neurons (Chen and Sara, 2007).
Nonsynaptic transmission may contribute to tonic NE release in the BLa which is
essential for arousal and attention (Berridge and Waterhouse, 2003).
BLa neurons exhibit heterogeneous, but prominently, inhibiting responses to
phasic LC activation (Chen and Sara, 2007). Studies using iontophoresis of NE into the
BLa found similar results (Buffalari and Grace, 2007). Responses were observed in
putative pyramidal neurons and interneurons identified based on firing rate and
antidromic activation by cortical stimulation (Buffalari and Grace, 2007, Chen and Sara,
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2007). Therefore our finding that NET+ terminals primarily synapse with CaMK+
pyramidal projection neurons is consistent with these electrophysiological results.
Previous studies revealed that increasing the activity of NE system has multiple
actions on different types of neurons in the BLC (Chen and Sara, 2007, Buffalari and
Grace, 2009), which is mediated by different types of adrenoceptors. It has been shown
that NE inputs to BLC exert potent α2 adrenergic receptor mediated inhibition of
spontaneous activity and attenuation of evoked activity for most pyramidal cells, but NE
also has excitatory effects mediated by β adrenergic receptors for a small portion of
pyramidal cells in BLC (Buffalari and Grace, 2007). Together with our findings, these
observations suggest that the effect of NE inputs on neuronal activity was determined by
localization of the adrenergic receptors expressed on BLa neurons. Further investigations
on the distribution and expression of different types of adrenergic receptors in BLa
neurons and glia will help to unravel how NE circuits modulate amygdalar activity.
Studies in humans and animals have shown that noradrenergic activation in the
amygdala is essential for the formation and recall of memories involving emotional
events (Berridge and Waterhouse, 2003, McGaugh, 2004). The N-methyl-D-aspartate
(NMDA) receptor is known to play a key role in synaptic plasticity underlying learning
and memory (Sigurdsson et al., 2007). Previous studies in rat BLa have shown that both
pyramidal cells and non-pyramidal cells exhibit NMDA receptor subunit 1 (NMDAR1)
immunoreactivity, and NMDAR1 is located in the dendrites and spines (McDonald,
1994b, Farb et al., 1995, Radley et al., 2007) . According to our observations, distal
dendritic shaft and spines are the major postsynaptic targets of NE inputs in the BLa,
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which suggests that NE inputs could affect synaptic plasticity by modulating NMDA
receptor activities.
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CHAPTER 4
MU OPIOID RECEPTOR LOCALIZATION IN THE RAT BASOLATERAL AMYGDALA

4.1 INTRODUCTION
The endogenous opioid system plays an important role in the process of stress adaptation
by attenuating or terminating stress responses (Drolet et al., 2001). Endogenous opioid
peptides including enkephalin, dynorphin and endorphin, produce their effects via three
major types of G-protein coupled receptors: mu, delta, and kappa (Drolet et al., 2001).
Preproenkephalin knock-out mice which have an endogenous deficit in enkephalin, elicit
stronger anxiety and depressive PTSD-like symptoms than wild type animals (Kung et
al., 2010). Overexpression of preproenkephalin in the amygdala potentiates the anxiolytic
effects of benzodiazepine (Kang et al., 2000). Considerable evidence indicates that mu
opioid receptors (MORs) in the BLA are also involved in stress related hypoalgesia
(Helmstetter et al., 1995, Helmstetter et al., 1998, Shin and Helmstetter, 2005). Although
BLA neurons do not directly project to nociceptive areas such as the periaqueductal gray
(PAG), the BLA has extensive connections with the central amygdala which has dense
reciprocal connections with the PAG (Hopkins and Holstege, 1978, Rizvi et al., 1991,
Harris, 1996). It is believed that MORs activation reduces the GABA inhibition to
pyramidal neurons in the BLA by modulating the presynaptic potassium channels and
therefore affects the neurotransmission in this BLA to PAG pathway (Helmstetter et al.,
1998, Finnegan et al., 2006, Sah, 2006). Additionally, the opioid system in the BLa has
been reported to be involved in regulating memory storage: the opiate antagonist
45

naloxone has been found to enhance retention in inhibitory avoidance and this effect can
be reversed by the mu opioid receptor (MOR) agonist DAMGO (Introini-Collison et al.,
1995).
Naloxone mainly binds to MOR, the most widely distributed opioid receptor in rat
brain (Mansour et al., 1987, Paden et al., 1987). Autoradiographic receptor binding
studies found that the amygdala contains dense MORs, and the BLA has a greater
abundance of MORs than the central amygdala (Mansour et al., 1987). Despite the fact
that MOR activation in the BLA is highly involved in regulation of stress response and
memory consolidation, little is known about how MOR affects neural activity in the
BLA. Knowledge about the ultrastructural localization of MORs in the BLA may help us
understand the underlying mechanism of opioid action. Electron microscopy combined
with immunocytochemistry was used in the present investigation to study the
ultrastructural localization of MORs in the BLa.
Early electrophysiological studies have shown that MOR activation can
hyperpolarize a subpopulation of interneurons and also disinhibit pyramidal cell by
inhibiting GABA release in the BLA, indicating that MORs may present in the cell
bodies, dendrites and axon terminals of some interneurons (Sugita and North, 1993). One
later study found that MOR activation also inhibits pyramidal cells via activating a
potassium current in their dendrites in the BLA, suggesting that MORs may be expressed
in the dendrites of pyramidal cells as well (Faber and Sah, 2004).
4.2 HYPOTHESIS
MORs are located in somata, dendrites and axon terminals of neurons in the BLa.
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4.3 METHODS
4.3.1 TISSUE PREPARATION
A total of five male Sprague-Dawley rats weighing 250-350g were used in this
study. Rats were handled in accordance with the principles of laboratory animal care and
protocols approved by the University of South Carolina Institutional Animal Care and
Use Committee. Rats were anesthetized with a ketamine mixture ( ketamine: 85mg/kg;
xylazine: 8mg/kg; acepromazine: 4mg/kg) and perfused intracardially with PBS
containing 1% sodium nitrite, followed by 2% paraformaldehyde-3.75% acrolein in
phosphate buffer(PB) for 1 minute, followed by 2% paraformaldehyde in PB for 20
minutes. Brains were removed and post-fixed in 2% paraformaldehyde for one hour.
Brains were sectioned on a vibratome in the coronal plane at 60 μm.
4.3.2 LIGHT MICROSCOPY IMMUNOHISTOCHEMISTRY
Light microscopy MOR localization was performed in rats using a rabbit antibody
to MOR antibody (1:1000, ImmunoStar, Hudson, WI). All antibodies were diluted in
PBS containing 0.4% Triton X-100 and 1% normal goat serum. Sections were incubated
in the primary antibody overnight at 4℃ and then processed for the avidin-biotin
immunoperoxidase technique using a biotinylated goat anti-rabbit secondary antibody (1:
500, Jackson Immunoresearch Laboratories, West Grove, PA) and a Vectastain standard
ABC kit (Vector laboratories, Burlingame, CA) with nickel-intensified 3,3´diaminobenzidine 4HCl (DAB, Sigma Chemical Co., St. Louis, MO, USA) as a
chromogen to generate a black reaction product (Hancock, 1986). After the reactions,
sections were mounted on gelatinized slides, dried overnight, dehydrated in ethanol,
cleared in xylene, and coverslipped in Permount (Fisher Scientific, Pittsburgh, PA, USA).
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Sections were analyzed with a Nikon E600 microscopy system and digital light
micrographs were taken with a Micropublisher digital camera.
4.3.3 ELECTRON MICROSCOPY IMMUNOHISTOCHEMISTRY
Immunoperoxidase methods were used to observe the ultrastructural localization
of MORs in the BLa. Sections were incubated in the MOR antibody (1:1000,
ImmunoStar, Hudson, WI) with 0.02% Triton-X overnight in a cold room after 30
minutes in a blocking solution (PBS containing 3% normal goat serum , 1% BSA and
0.02% Triton-X). All antibodies were diluted in the blocking serum. Then sections were
processed using a biotinylated goat anti-rabbit antibody (1:500, Jackson
ImmunoResearch, West Grove, PA) and a Vectastain standard ABC kit (Vector
Laboratories, Burlingame, CA). MOR immunoreactivity was then visualized using a
Vector-VIP (Very Intense Purple) peroxidase substrate kit (Vector Laboratories,
Burlingame, CA). This step produced a reaction product that appears purple in the light
microscope and granular in the electron microscope.
4.3.4 PROCEDURE FOR ELECTRON MICROSCOPY
Sections were then post-fixed in 2% osmium tetroxide in 0.16 M sodium
cacodylate buffer for one hour, dehydrated in ethanol and acetone, and flat embedded in
Polybed 812 (Polysciences, Warrington, PA) in slide molds between sheets of Aclar (Ted
Pella, Redding, CA). Selected areas of the BLa were remounted onto resin blanks. Silver
thin sections were collected on formvar-coated slot grids, stained with uranyl acetate and
lead citrate and examined with a JEOL-200CX electron microscope. Micrographs were
taken with an AMT XR40 digital camera system (Advanced Microscopy Techniques,
Danvers, MA).
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4.3.5 ANALYSIS
Vibratome sections from three rats (one for each animal) with the best labeling
quality were selected for thin sectioning and analysis. From these sections, areas with the
best morphology and immunohistochemistry for MORs were chosen for quantitative
analysis. About 3600 μm2 area from each section was used for counting and a total of
2378 labeled profiles were counted. Numbers from three rats were pooled together for
analysis. Medium or large structures (≥0.2μm) were counted as labeled only if they
contained two or more labeled granules. Small structures (<0.2μm) were counted as long
as they contained one labeled granule. MOR+ profiles were identified as somata, large
caliber dendritic shafts (diameter ≥1μm), small caliber dendritic shafts ( diameter <1μm),
spines, axons, axon terminals, and glia processes according to established morphological
criteria (Peters A, 1991). MOR labeled terminals were followed and fully or partially
reconstructed in 3 to 13 serial thin sections. Serial sections were helpful for verifying
label in small and/or lightly immunoreactive structures, and for determining synaptic
contacts. MOR labeled terminals were considered to form synapses if they showed the
following characteristics: 1) parallel presynaptic and postsynaptic membranes exhibiting
membrane thickening, 2) clustered vesicles associated with the presynaptic membrane,
and 3) a synaptic cleft containing dense material. Asymmetrical and symmetrical
synapses were identified based on the presence or absence of a prominent postsynaptic
density and the widths of their synaptic clefts. Asymmetrical synapses usually have wider
synaptic clefts (20nm) than symmetrical ones (12nm) (Peters A, 1991). Postsynaptic
neuronal profiles receiving synapses from MOR labeled terminals were identified as
MOR labeled or unlabeled somata, large caliber dendritic shafts (diameter ≥1μm), small
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caliber dendritic shafts (diameter <1μm), or spines according to established
morphological criteria (Peters A, 1991)
4.3.6 ANTIBODY SPECIFICITY
The rabbit polyclonal MOR antiserum (ImmunoStar, Cat. 24216) used in this
study was raised against a synthetic peptide corresponding to amino acids 384-398 of the
carboxyl terminus of the rat MOR1 coupled to bovine thyroglobulin with glutaraldehyde.
Specificity of this antibody has been well documented in previous studies (Gracy et al.,
1997, Deng et al., 2007, Likhtik et al., 2008). An earlier study in our lab demonstrated
that pre-absorption of the MOR antiserum with MOR eliminated all immunostaining, but
cross-absorption of MOR antiserum with non-matching peptides did not affect
immunostaining (Wilson et al., 2002).
4.4 RESULTS
4.4.1 LIGHT MICROSCOPY OBSERVATIONS
At the light microscopy level, MOR immunoreactivity (MOR-ir) presents a wide
uneven distribution through the amygdala, consistent with the dense but differential
DAMGO binding in the individual amygdala nuclei observed in the autoradiographic
binding studies (Mansour et al., 1987). Strongest staining was found in the intercalated
nuclei (Figure 4.1). Much lighter neuropil labeling was observed in the basolateral
amygdala (Figure 4.1.A). Few interneurons were found labeled in their somata and
processes in both the BLa and lateral nucleus of the amygdala (Figure 4.1.B). These
findings are consistent with previous light microscopy immunohistochemistry studies
(Ding et al., 1996, Wilson et al., 2002).
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4.4.2 ELECTON MICROSCOPY OBSERVATION
At the electron microscopy level, MOR positive (MOR+) structures included
somata, dendritic shafts, spines, axon terminals, thin unmyelinated or myelinated axons,
and glia processes (Figure 4.2). Only three MOR+ somata were found in our
preparations. One MOR+ soma had a round smooth nuclear membrane and a modest
amount of cytoplasm, which are characteristics of pyramidal cells (Figure 4.3.A). In the
other case, a soma received multiple asymmetrical synapses, typical of interneurons
(Figure 4.3.B). In these MOR+ somata, the MOR-ir was seen in the cytoplasm and was
found associated with the Golgi apparatus or endoplasmic reticulum (Figure 4.4).
The most frequently labeled structures in the neuropil were dendritic structures.
Counts of MOR+ profiles revealed that large-caliber dendrites, small caliber dendrites
and spines comprised 11.1% (265/2378), 50.5% (1200/2378) and 10.8% (258/2378) of all
MOR+ profiles, respectively (Figures 4.2, 4.4-4.6). It is impossible to definitely identify
the cell type of origin of these MOR+ dendrites, based only on their morphological
features. Nevertheless, the presence of spines on some MOR+ dendrites suggests that
they may belong to pyramidal cells (Figures 4.4.B, 4.5.B and 4.5.C) (Muller et al., 2006)
. We also found several dendrites received multiple asymmetrical synapses (Figure
4.4.C), which is a characteristic of interneuronal dendrites in the BLa (Muller et al.,
2011). MOR-ir in these labeled dendrites and spines was mainly cytoplasmic (Figures
4.4-4.6 and 4.8), but MOR+ labeling near the plasma membranes was observed in many
cases as well (Figures 4.5and 4.8).
MOR-ir was also seen in small unmyelinated or myelinated axons, but only in a
few cases. However, MOR labeling was commonly observed in axonal terminals,
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constituting 20.9% (497/2378) of MOR+ profiles (Figure 4.2). V-VIP particulate reaction
product in these MOR labeled terminals was often associated with synaptic vesicles, near
the active zone or occurred randomly in the varicosities (Figures 4.3.A, 4.4.C, 4.5.A,
4.5.C and 4.8). About 40% (197/497) of MOR+ terminals formed synapses. MOR+
terminals formed synapses with both labeled and unlabeled profiles, and their
postsynaptic targets included somata, large and small dendritic shafts, and spines (Figures
4.3.A. 4.4.C 4.7 and 4.8) (Table 4.1). Both asymmetrical (82%, 162/197) and
symmetrical synapses (18%, 35/197) were observed, but asymmetrical synapses were
more common (Figures 4.3.A, 4.4.C, 4.7 and 4.8) (Table 4.1). The main postsynaptic
targets of MOR+ terminals were unlabeled spines (61%, 121/197, asymmetrical 97%
symmetrical 3%), labeled spines (13%, 25/197, asymmetrical 80%, symmetrical 20%)
and labeled small caliber dendritic shafts (13%, 25/197, asymmetrical 44%, symmetrical
56%) (Figures 4.3.A, 4.4.C, 4.7) (Table 4.1). Some MOR + terminals form large
asymmetrical synapses, suggesting that they might be glutamatergic (Figures 4.8.C-E)
(LeDoux et al., 1991, Stefanacci et al., 1992, Brinley-Reed et al., 1995).
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Figure 4.1 Light micrographs of MOR immunohistochemistry in the BLa using nickelDAB as a chromogen in an immunoperoxidase preparation. A: Low power micrograph
illustrating MOR immunohistochemistry in the BLa, lateral nucleus (La), central nucleus
(Ce) and intercalated nuclei (stars) at bregma level -2.1. B: High power micrograph
illustrating one MOR+ interneuron (arrow) and nearby MOR+ punctate structure (star),
possibly a MOR+ dendritic shaft. Scale bar=50μm in A; 10μm in B.
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Table 4.1 Postsynaptic targets of MOR+ terminals in the BLa.
So0

LD3

SD8

Asymmetrica
l MOR+
0
1.9% 4.9%
Synapses
2
0
2
Symmetrical
MOR+
5.7%
0
5.7%
Synapses
2
3
10
Total MOR+
1% 1.5% 5.1%
Synapses

LD+
2

SD+
11

Sp+
20

Total
162

72.3%
4

0.6% 1.2%
1
7

6.8%
14

12.3%
5

100%
35

11.4%
121
61.4%

2.9% 20%
2
9
1% 4.6%

40%
25
12.7%

14.3%
25
12.7%

100%
197
100%

Sp117

So+
1

Note: So-: Unlabeled Soma; LD-: unlabeled large dendrite (diameter ≥1μm); SD-:
unlabeled small dendrite (diameter <1μm); Sp-: unlabeled spine; So+: MOR+ spines;
LD+: MOR+ large dendrite (diameter ≥1μm); SD+: MOR+ small dendrite (diameter
<1μm); Sp: MOR+ spines.
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Figure 4.2 Histogram showing the number of each MOR+ structure observed in
the quantitative analysis of the BLa. So: Soma; LD: large caliber dendrite
(diameter ≥1μm); SD: small caliber dendrite (diameter <1μm); Sp: spine; T:
terminal; Ax: axon; G: glial.
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Figure 4.3 Electron micrographs of MOR+ somata in the BLa. A: A MOR+ soma (M-So) is
contacted by a MOR+ terminal (M-t), forming a symmetrical synapse (arrow). MOR-ir is
present near the Golgi apparatus. B: A MOR+ soma (M-So) receiving asymmetrical synaptic
contacts from two unlabeled terminals (arrow). Arrowheads show granule MOR label.
Arrowheads point to the MOR labeling. Scale bar=0.5μm.

56

Figure 4.4 Electron micrographs of MOR+ large caliber (≥1μm) dendrites. A: A
large caliber MOR+ dendrite (M-LD) and two nearby small caliber MOR+ dendrites
(M-SD) B: A large caliber MOR+ dendrite (M-LD) with a MOR+ spine (M-Sp). The
spine suggests that this dendrite may belong to a pyramidal cell. C: A longitudinally
sectioned large caliber MOR+ dendrite receives multiple asymmetrical synapses
(arrow) from either MOR+ (M-t) or unlabeled (U-t) terminals, suggesting that this
dendrite may belong to an interneuron. Arrowheads show granules of MOR label.
Arrowheads point to the MOR labeling. Scale bar=0.5μm.
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Figure 4.5 Electron micrographs of MOR+ small caliber (<1μm)
dendrites. A: A long MOR+ small caliber dendrite (M-SD) and adjacent
MOR+ (M-t) or unlabeled (U-t) axon terminals which both form
asymmetrical synapses (arrows) with a MOR+ spine (M-Sp). There is
another small caliber dendrite (M-SD) nearby. B: Two small caliber
MOR+ dendrites (M-SD), one of which has a spine (Sp), suggesting that
it might belong to a pyramidal cell. C: One small caliber MOR+
dendrites (M-SD) with a spine (Sp) contacted (stars) by a MOR+
terminal (M-t), suggesting it might belong to a pyramidal cell. There is
another MOR+ terminal (M-t) nearby. Arrowheads show granules of
MOR labeling. Scale bar=0.5μm.

58

Figure 4.6 Electron micrograph of MOR+ spines. Two MOR+ spines receive
asymmetrical synaptic contacts (arrows) from unlabeled terminals (Ut). Arrowheads
show granules of MOR label. Arrowheads point to the MOR labeling. Scale bar=0.5µm.
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Numbers of Synapses formed by
MOR+ Terminals

Postsynaptic Targets of MOR+ Terminals
140
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Postsynaptic Targets of MOR+ Terminals

Figure 4.7 Histogram showing the number of symmetrical (S, Black) or asymmetrical
(AS, dark gray) synapses of MOR+ terminals with various MOR labeled (+) or
unlabeled (-) structures. So: soma; LD: large caliber dendrite (≥1μm); SD: small caliber
dendrite (<1μm); Sp: spine;
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Figure 4.8 Electron micrographs of various postsynaptic
targets of MOR+ terminals. A: A MOR+ terminal (M-t)
forms a symmetrical synapse (arrows) with an unlabeled
cell body (U-CB). There are two MOR+ small caliber
dendrites (M-SD) nearby. B: A MOR+ terminal (M-t) form
a symmetrical synapse (arrows) with a MOR+ small caliber
dendrite (M-SD). C: Two MOR+ terminals (M-t) form
asymmetrical synapses (arrows) with an unlabeled small
caliber dendrite (U-SD) which also receives an
asymmetrical synapse from an unlabeled terminal (U-t).
Multiple asymmetrical synapses are indicative of
interneuronal dendrite. D: A MOR+ terminal (M-t) form an
asymmetrical synapse (arrows) with a MOR labeled spine
(M-Sp). E: A MOR+ terminal (Mt) form an asymmetrical
synapse (arrows) with a MOR labeled spine (M-Sp).
Arrowheads show granules of MOR label. Arrowheads
point to MOR label. Scale bar=0.5µm.
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4.5 DISCUSSION:
The electron microscopy analysis of MOR distribution in the BLa revealed that
MOR-ir is present in diverse populations of neuronal profiles and glial processes as well.
The most frequently labeled structures were small caliber dendrites and terminals. MOR+
terminals formed synapses with both labeled and unlabeled profiles. The main
postsynaptic targets of MOR+ terminals forming asymmetrical synapses were unlabeled
spines, while the main targets of MOR+ terminals forming symmetrical synapses were
MOR+ small caliber dendritic shafts.
4.5.1 ANATOMICAL CONSIDERATIONS
The ultrastructural distribution of MOR in the BLa was consistent with previous
MOR binding and immunohistochemistry studies in the amygdala, which revealed dense
MOR binding and high level of MOR immunoreactivity in the basolateral amygdala.
(Mansour et al., 1987, Ding et al., 1996). Similar to previous research in the central
amygdala and a very limited analysis in the BLa (Glass et al., 2005, Glass et al., 2009),
MOR immunoreactivity was found in both pre and post-synaptic neuronal profiles in the
present study.
Counts of MOR+ structures showed that small distal dendrites are most
commonly labeled. Although we could not determine their cell type of origin based only
on their anatomical features, some of these dendrites exhibited spines, a characteristic of
pyramidal cell dendrites. In addition, the large numbers of spines and dendrites in the
labeled profiles suggests that they are coming from pyramidal cells since 85% of BLa
neurons are pyramidal cells (McDonald, 1992). Very few dendrites received multiple
asymmetrical synaptic contacts, which is typical of interneurons. Together, these findings
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indicate that most of the MOR+ dendrites appear to belong to pyramidal projection
neurons, but some are interneurons.
MOR+ terminals formed synapses with both labeled and unlabeled profiles, and
their postsynaptic targets included somata, large and small caliber dendritic shafts, and
spines. Both symmetrical and asymmetrical synapses were observed, but asymmetrical
synapses were more common. Since most asymmetrical synapses are glutamatergic in the
BLa (Pare et al., 1995), the majority of MOR+ terminals might be glutamatergic.
Moreover the major postsynaptic targets of MOR+ terminals were spines, which is also
the main target of glutamatergic projections to the BLa from cortical, thalamus and other
nuclei of amygdala (LeDoux et al., 1991, Stefanacci et al., 1992, Brinley-Reed et al.,
1995), which further confirms this possibility. Additionally, it has been reported that
opioids inhibit NE release in the amygdala during stress (Quirarte et al., 1998), thus some
of MOR+ terminals might be noradrenergic, in particular those forming symmetrical
synapses, which is the major synapse type formed by noradrenergic inputs in the BLa
(Zhang et al., 2013).
MOR labeling in our preparation was found to be more commonly associated with
cytoplasmic organelles, but the MOR-ir was also found near the plasma membrane in
many cases as well. MOR has to be inserted into membrane to be functional. Although
the V-VIP particles do not represent the precise location of the antigen due to diffusion of
the peroxidase reaction product, it is highly possible that the MOR-ir near the plasma
membrane may reflect membrane-associated receptors and the ones associated with
cytoplasmic organelles may serve as a reserve pool of MORs or be in the process of
being transported to other parts of neurons. Actually, ultrastructural studies using
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immunogold techniques, which provide more accurate antigen localization, have found
that MOR-ir was located both in the cytoplasm and plasmalemma in the central lateral
amygdala (Glass et al., 2009, Beckerman and Glass, 2011). Conversely, earlier
immunogold studies reported that the MORs are almost exclusively located in
plasmalemma in the striatal patch compartment (Wang et al., 1996, Wang and Pickel,
2001) and the shell of nucleus accumbens (Gracy et al., 1997). Future studies using
immunogold techniques are required to provide a more precise subcellular distribution of
MORs in the BLa.
4.5.2 FUNCTIONAL IMPLICATIONS
The fact that MOR-ir was observed in both pre and post synaptic profiles suggests
that MOR can modulate BLa neurons both pre and postsynaptically, which agrees with
electrophysiological results indicating that MOR activation leads to membrane
hyperpolarization and inhibits neurotransmitter release in the BLC (Sugita and North,
1993, Faber and Sah, 2004, Finnegan et al., 2006).
Although MOR activation is associated with inhibition of amygdala function
(Liberzon et al., 2002) in general, the effects of MOR activation on the individual
neurons is complicated. A previous study reported that MOR activation hyperpolarizes a
subpopulation of neurons and inhibits GABA release in the lateral amygdala (LA) (Sugita
and North, 1993), indicating that MOR may be located in the terminals of interneurons in
the LA. Another study in the BLA found that activation of presynaptic MOR receptors
primarily attenuates GABAergic inputs to the central amygdala projecting pyramidal
cells in the BLA though Kv1.1/1.2 channels (Finnegan et al., 2006), which also suggest
that the MOR activation probably occurs in interneuronal terminals. This is consistent
with our observations that some of the MOR+ axon terminals in the BLa form
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symmetrical synapses, typical of GABAergic inhibitory interneuron (McDonald and
Mascagni, 2002). This MOR induced GABA release inhibition, and hence pyramidal cell
disinhibition, may also contribute to stress associated hypoalgesia through the BLAcentral amygdala- PAG pathway (Hopkins and Holstege, 1978, Rizvi et al., 1991, Harris,
1996). Moreover, we also observed a few MOR+ interneurons, which may be part of the
hyperpolarized subpopulation during MOR activation in the earlier study (Sugita and
North, 1993). Additionally, many MOR+ dendrites in present preparation have been
found to give rise to spines, which is characteristic of pyramidal cells. These MORs in
dendrites may modulate pyramidal cell excitability via affecting potassium channels,
which have been shown in the LA (Faber and Sah, 2004).
Considering that dendritic spines of pyramidal cells in the BLa are also the major
target of excitatory inputs from the cortex, thalamus and pyramidal neurons of the LA
and BLA (LeDoux et al., 1991, Stefanacci et al., 1992, Brinley-Reed et al., 1995), MOR
might be involved in modulating the effects of these inputs to BLa pyramidal cells. In
fact, MORs have been found to be closely colocalized with glutamatergic receptors in the
BLa (Glass et al., 2005), which may contribute to the neuronal plasticity in the amygdala
related to opioid addiction (Scavone et al., 2011). Spines in the BLa are also major neural
compartments receiving modulatory inputs such as cholinergic, norepinephrine,
dopamine and serotonin (Muller et al., 2011, Zhang et al., 2013) (Muller et al., 2007,
2009) indicating that MOR could postsynaptically influence their effects on the BLa as
well.
The majority of the asymmetrical synapses formed by MOR+ terminals may be
glutamatergic since most asymmetrical synapses are glutamatergic in the BLa (Pare et al.,
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1995). It is highly possible that MORs may be involved in modulation of glutamate
release in the BLa. Some of the symmetrical synapses formed by MOR+ terminals might
be noradrenergic. A recent ultrastructural study demonstrated that noradrenergic inputs
mainly form symmetrical synapses in the BLa (Zhang et al., 2013). MORs in
noradrenergic terminals might explain the effects of opioid peptidergic drug
administration on norepinephrine release in the amygdala (Quirarte et al., 1998), which is
thought to be the major way that opioids are involve in memory modulation during stress
(Introini-Collison et al., 1995, McGaugh, 2004).
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CHAPTER 5
LIMITED CONVERGENCE OF ENKEPHALIN AND NOREPINEPHRINE INPUTS IN THE
RAT BASOLATERAL AMYGDALA

5.1 INTRODUCTION
Accumulating evidence indicates that norepinephrine (NE) and opioid systems in
the amygdala are heavily involved in stress adaptation and memory consolidation of
emotionally arousing experiences (Introini-Collison et al., 1995, Drolet et al., 2001,
McGaugh, 2004, Roozendaal et al., 2009). Studies have shown that stressful stimuli such
as footshock induce norepinephrine release in the rat amygdala (Galvez et al., 1996,
Quirarte et al., 1998). Moreover, post-training drug treatment studies using adrenergic
agonists and antagonists indicate that activating the NE system in the basolateral
amygdala enhances memory retention of inhibitory avoidance (Ferry and McGaugh,
1999, McGaugh, 2004, Ferry and McGaugh, 2008).
Endogenous opioid peptides include endorphin, enkephalin (ENK) and dynorphin
derived from three peptide precursors, proopiomelanocortin (POMC), proenkephalin
(ProEnK) and prodynorphin (ProDyn), respectively (Stefano et al., 2000, Drolet et al.,
2001). These opioid peptides produce their effects via three types of G-protein coupled
receptors: mu, delta and kappa. Preproenkephalin knockout mice elicit stronger anxiety
and depressive PTSD-like symptoms than wild type animals (Kung et al., 2010). In
addition, the opiate antagonist naloxone has been found to enhance memory retention in
inhibitory avoidance and this effect could be reversed by mu opiate receptor (MOR)
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agonists (Izquierdo and Graudenz, 1980, Introini-Collison et al., 1989, Introini-Collison
et al., 1995). The memory regulating effects of opioids are believed to be mediated
through the modulation of the NE system, since intra-amygdala activation of MORs
impairs memory by inhibiting NE release, and facilitating NE function compensates this
memory impairment effects (Introini-Collison et al., 1995). Considering the sparse
projection to the BLa from beta-endorphin expressing neurons in hypothalamus (Gray et
al., 1984), ENK may be the major endogenous opioid peptide which is involved in the
memory modulation function of MORs in the amygdala.
The major postsynaptic targets of NE inputs in the BLa are distal dendrites and
spines (Zhang et al., 2013), which are also the main MOR+ profiles (results from chapter
4). Thus it is possible that NE inputs and ENK inputs may both synapse with these
postsynaptic structures, similar to the locus ceruleus where ENK and epinephrine
terminals converge on the same structures (Van Bockstaele et al., 1996). However, there
have been no ultrastructural studies examining the convergence of NE and ENK
terminals in the BLa. Also, there have been no previous electron microscopy
investigations of ENK in the BLa. All the previous studies have concentrated on
examining the presynaptic interaction of ENK and NE system (Izquierdo and Graudenz,
1980, McGaugh et al., 1988, Introini-Collison et al., 1989, Introini-Collison et al., 1995,
Quirarte et al., 1998). The present study utilized dual-immunocytochemistry staining
combined with electron microscopy to investigate the extent of the convergence of NE
and ENK terminals onto common structures in the BLa, which will provide information
about whether there may also be postsynaptic interactions of NE and ENK in the BLa.
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5.2 HYPOTHESIS
There may be convergence of NE and ENK inputs on distal dendritic shafts and spines of
BLa neurons.
5.3 METHODS
5.3.1 TISSUE PREPARATION
Five male Sprague-Dawley rats weighing 250-350g were used in this study. Rats
were handled in accordance with the principle of laboratory animal care and protocols
approved by the University of South Carolina Institutional Animal Care and Use
Committee. Brain tissue was prepared as described in previous studies of our lab (Muller
et al., 2011) . Rats were anesthetized with a ketamine mixture (ketamine: 85mg/kg;
xylazine: 8mg/kg; acepromazine: 4mg/kg) and perfused intracardially with PBS
containing 1% sodium nitrite, followed by 2% paraformaldehyde-3.75% acrolein in
phosphate buffer (PB) for 1 minute, followed by 2% paraformaldehyde in PB for 20
minutes. Brains were removed and post-fixed in 2% paraformaldehyde for one hour.
Brains were sectioned on a vibratome in the coronal plane at 60μm.
5.3.2 LIGHT MICROSCOPY IMMUNOHISTOCHEMISTRY
Single-label localization of ENK was performed in two rats using a rabbit
antibody to methionine-enkephalin (met-ENK) (1:1000, ImmunoStar, Hudson, WI). All
antibodies were diluted in PBS containing 0.4% Triton X-100 and 1% normal goat
serum. Sections were incubated in the primary antibody overnight at 4℃ and then
processed for the avidin-biotin immunoperoxidase technique using a biotinylated goat
anti-rabbit secondary antibody (1: 500, Jackson Immunoresearch Laboratories, West
Grove, PA) and a Vectastain standard ABC kit (Vector laboratories, Burlingame, CA)
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with nickel-intensified 3,3´-diaminobenzidine 4HCl (DAB, Sigma Chemical Co., St.
Louis, MO, USA) as a chromogen to generate a black reaction product (Hancock, 1986).
After the reactions, sections were mounted on gelatinized slides, dried overnight,
dehydrated in ethanol, cleared in xylene, and coverslipped in Permount (Fisher Scientific,
Pittsburgh, PA, USA). Sections were analyzed with a Nikon E600 microscopy system
and digital light micrographs were taken with a Micropublisher digital camera.
5.3.3 DOUBLE LABELING ELECTRON MICROSCOPY
IMMUNOHISTOCHEMISTRY
Double labeling immunohistochemistry was performed to detect the convergence
extent of NE and ENK terminals in the BLa at the electron microscopy level. To enhance
penetration of antibodies, sections were incubated with low level of Triton-X-100
(0.02%) in the antibody dilutions. Section were incubated in a mouse monoclonal NET
antibody (1:2000 NET-05, obtained from Dr. Randy D. Blakely, Vanderbilt University
Medical Center) overnight at 4℃ after 30 minutes in a blocking solution (PBS containing
3% normal goat serum , 1% BSA and 0.02% Triton-X), and then processed using a
biotinylated goat anti-mouse antibody (Jackson ImmunoResearch, West Grove, PA) and
a Vectastain standard ABC kit (Vector Laboratories, Burlingame, CA) with 3,3´diaminobenzidine 4HCl (DAB, Sigma Chemical Co., St. Louis, MO, USA) as the
chromogen. After rinsing, sections were incubated in an avidin/biotin blocking solution
(Vector Laboratories, Burlingame, CA). Sections were then incubated overnight at 4℃ in
rabbit anti-met-enkephalin antibody (1:1000, ImmunoStar) to label ENK structures. For
ENK immunohistochemistry, sections were processed using a biotinylated goat antirabbit secondary antibody (1: 500, Jackson Immunoresearch Laboratories, West Grove,
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PA) and an Elite ABC kit (Vector Laboratories, Burlingame, CA), with Vector-VIP as a
chromogen. This process produces a reaction product that appears purple at the light
microscopy level and granular at the electron microscopy level. It was easily
distinguished from the diffuse DAB immunoperoxidase reaction product at the
ultrastructural level.
5.3.4 PROCEDURE FOR ELECTRON MICROSCOPY
After the immunohistochemical reactions, sections were then post-fixed in 2%
osmium tetroxide in 0.16 M sodium cacodylate buffer for one hour, dehydrated in ethanol
and acetone, and flat embedded in Polybed 812 (Polysciences, Warrington, PA) in slide
molds between sheets of Aclar (Ted Pella, Redding, CA). Selected areas of the BLa were
remounted onto resin blanks. Silver thin sections were collected on formvar-coated slot
grids, stained with uranyl acetate and lead citrate and examined with a JEOL-200CX
electron microscope. Micrographs were taken with an AMT XR40 digital camera system
(Advanced Microscopy Techniques, Danvers, MA).
5.3.5 ANALYSIS
Vibratome sections from three rats (one for each animal) with the best labeling
quality were selected for thin sectioning and analysis. From these thin sections, areas
with the best morphology and robust presence of both NET and ENK labels were chosen
for quantitative analysis. During data collection, each NET + terminal was centered in the
field and then MOR+ terminals in the same field as the NET+ terminal were counted and
used for analysis. All the pictures were taken at the 36,000 magnification in which the
area of each field is around 4.4×5.5 μm2. Labeled terminals were followed for 3 to 11
serial thin sections. Contacts of NET+ and ENK+ terminals with ENK labeled or
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unlabeled neuronal structures in the BLa were classified as either synapses or apposition.
Synapses were identified using standard criteria: 1) parallel presynaptic and postsynaptic
membranes exhibiting membrane thickening, 2) clustered vesicles associated with the
presynaptic membrane, and 3) a synaptic cleft containing dense material. Contacts which
did not meet these criteria were identified as appositions. Asymmetrical and symmetrical
synapses were identified based on the presence or absence of a prominent postsynaptic
density and the widths of their synaptic clefts. Asymmetrical synapses usually have wider
synaptic clefts (20nm) than symmetrical ones (12nm) (Peters A, 1991). Postsynaptic
neuronal profiles receiving synapses from ENK-labeled terminals were identified as
ENK- labeled or unlabeled somata, large caliber dendritic shafts (diameter ≥1μm), small
caliber dendritic shafts (diameter <1μm), or spines according to established
morphological criteria (Peters A, 1991). The percentage of labeled terminals (NE or
ENK) contacting a common structure was determined. In addition, the percentage of
terminals contacting each other was determined as well.
5.3.6 ANTIBODY SPECIFICITY
The mouse monoclonal anti-NET primary antibody (1:2000 NET-05, obtained
from Dr. Randy D. Blakely, Vanderbilt University Medical Center) used in this study was
raised against amino acids 5-17 of the amino-terminus of mouse NET. Specificity of this
antibody has been demonstrated by absence of immunolabeling in NET knock out tissue
or following pre-adsorption in previous studies (Matthies et al., 2009, Erickson et al.,
2011).
The met-enkephalin antibody used in present study has been well documented in
the previous studies (Wilson et al., 2002). It has very limited recognition of leucine-ENK
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and has no cross reaction with endorphin or dynorphin (Cheng et al., 1995, Wilson et al.,
2002).
Two control groups were used in the experiment. First group omitted ENK
primary antibody but was performed all the same procedure as double labeling group,
second group omitted NET primary antibody but was performed all the same procedures
as the double labeling group. No purple labels were observed in the first group. No DAB
labels were observed in the second group. Therefore the secondary antibodies were
specific for mouse or rabbit IgG.
5.4 RESULTS
5.4.1 LIGHT MICROSCOPY OBSERVATIONS
At the light microscopy level, ENK immunoreactivity (ENK-ir) presents a
distribution pattern which is similar to the observation in a previous study (Wilson et al.,
2002). Dense neuropil staining was found in the neuropil of the intercalated nuclei
(Figure 5.1.A). ENK+ somata were observed mainly in the central nucleus and only a few
ENK+ nonpyramidal interneurons were found in the lateral and basolateral amygdala
(Figure 5.1), which is consistent with results of a preproenkephalin mRNA binding study
(Harlan et al., 1987). Moderate neuropil labeling was found in the central amygdala but
there was only very light neuropil labeling in lateral and basolateral amygdala
(Figure5.1.A).
5.4.2 ELECTRON MICROSCOPY OBSERVATIONS
Dual labeling using ENK and NET antibodies show that both labels are
concentrated in terminals (Figures 5.2-5.4). ENK immunoreactivity (ENK-ir) was also
seen in somata, dendrites, spines and axons (Figures 5.2 and 5.3.A). ENK terminals were
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round to ovoid with small vesicles that were round and clear (Figures 5.2.A, 5.3 and 5.4).
About 70% (110/157) of ENK+ terminals formed synapses with either ENK+ or
unlabeled structures (Figures 5.2.A, 5.3 and 5.4.A). Postsynaptic targets of these ENK+
terminals included ENK+ and unlabeled dendritic shafts and spines (Figures 5.2A, 5.3
and 5.4.A). ENK+ terminals mainly formed asymmetrical synapses and their most
frequent targets were the ENK+ or unlabeled spines (Figures 5.2.A). In a few cases
symmetrical synapses formed by ENK+ terminals were observed and most of them were
with small distal dendritic shafts (Figures 5.3.A).
NET+ profiles consisted of thin unmyelinated axons and varicosities containing
synaptic vesicles (Figures 5.2-5.4). The peroxidase reaction product was distributed
throughout these NET + profiles, with accumulations near the plasma membrane and the
outer membrane of vesicles and mitochondria. This diffuse DAB reaction product was
easily distinguished from the particulate Vector-VIP reaction product of ENK labeling.
NET+ terminals were round or ovoid in shape with closely packed small, round clear
synaptic vesicles, sometimes associated with large clear vesicles, similar to the
descriptions of DBH+ profiles and NET+ profiles reported in previous studies of the
basolateral amygdala (Asan, 1998, Li et al., 2001, Li et al., 2002, Farb et al., 2010, Zhang
et al., 2013). NET terminals mainly formed symmetrical synapses and they targeted both
ENK+ and unlabeled structures, including, dendritic shafts, spines and somata, consistent
with previous studies (Li et al., 2001, Li et al., 2002, Zhang et al., 2013).
There was a very limited convergence of NET and ENK inputs in the BLa. 11%
of ENK terminals (17/157) contacted a common neuronal structure with an NET terminal
in the same field (Figures 5.3-5.5). The targets and types of contacts formed by
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converging terminals were described in Table 5.1. In general, the most frequent common
targets were small caliber dendritic shafts and spines (Figures 5.3 and 5.4) (Table 5.1).
For one case, NET+ and ENT+ terminals contacted the same ENK+ cell body. Similarly,
a large caliber dendritic shaft was observed only once to be a common target of NET and
NET terminals. In most instances of convergence, ENK+ terminals formed asymmetrical
synapses or appositions whereas NET+ terminals formed symmetrical synapses or
appositions (Figures 5.3 and 5.4) (Table 5.1). In addition, NET+ and ENK+ terminals
contacted each other in five cases (Figures 5.3.B and 5.4.B)
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Figure 5.1 Light micrographs of ENK immunohistochemistry in the BLa using nickel
DAB as a chromogen in an immunoperoxidase preparation. A: Low power micrograph
illustrating ENK immunohistochemistry in the BLa, lateral nucleus (La), central
nucleus (Ce) and intercalated nuclei (stars) at bregma level-2.1.B: Higher power
micrograph of the boxed area in A, illustrating several ENK+ interneurons (arrows). C:
High power micrograph illustrating an ENK+ interneuron (arrow) and its processes
(stars). Punctate ENK+ structures (arrow head) maybe ENK+ axon terminals. Scale
bar=100μm in A, 50μm in B, 10μm in C.

76

Figure 5.2 Electron micrographs of the BLa
immunostained for NET and ENK. A: A NET+
terminal (t-NET) and an ENK+ terminal (t-ENK)
are found in the same field, but they do not target
the same structure. The ENK+ terminal forms an
asymmetrical synapse (arrow) with an unlabeled
spine (U-sp). The NET terminal contacts (asterisk)
an ENK+ small caliber dendrite (ENK-SD). There
are also an ENK+ spine (ENK-Sp) and ENK+ small
caliber dendrite (ENK-SD) in this field. B: A
NET+ terminal forms an apposition (asterisk) with
an ENK+ small caliber dendrite (ENK-SD) and a
spine (Sp) arising from it. There is an ENK+ spine
(ENK-Sp) and an ENK+ myelinated axon (ENKAx) nearby as well. Arrowhead indicates Vector
VIP granule labeling. Scale bar=0.5μm.
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Figure 5.3 Electron micrographs showing synaptic convergence of NET+ and ENK+
terminals in the BLa. A: A NET+ terminal (t-NET) and an ENK+ terminal (t-ENK)
target (arrow) the same ENK+ small caliber dendrite (ENK-SD), both forming
symmetrical synapses (arrows). ENK labeling in this small dendrite is much more
obvious in the adjacent sections. B: An unlabeled spine (U-Sp) receives symmetrical
synapses (arrows) from NET+ and ENK + terminals. Arrowheads indicate V-VIP
granule labeling. Scale bar=0.5μm.

78

Figure 5.4 Electron micrographs showing convergence of NET+ and ENK+ terminals
in the BLa. A: A NET+ terminal (t-NET) forms a symmetrical synapse (arrow) with
an unlabeled small caliber dendrite (U-SD). An ENK+ terminal (t-ENK) form an
apposition (asterisk) with the same dendrite. B: A NET+ terminal and an ENK+
terminal form appositions with an unlabeled SD (U-SD) and with each other.
Arrowheads indicate V-VIP granule labeling. Scale bar=0.5μm.
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Numbers of Neuronal Profiles
Contacted by Coverging ENK+ and
NET+ Terminals

Summary of Structures Contacted By
Converging ENK+ and NET+ Terminals
6
5
4
3
2
1
0
So+

So-

LD+

LD-

SD+

SD-

Sp+

Sp-

Figure 5.5 Histogram showing numbers of each type of neuronal profiles in
the BLa contacted by converging ENK+ and ENT+ terminals. +: ENK
labeled; -: unlabeled; So: soma; LD: large caliber dendrite (diameter
≥1μm); SD: small caliber dendrite (diameter <1μm); Sp: spine;
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Table 5.1 Targets and types of contacts of converging
ENK+ terminals and NET+ terminals in the BLa.
ENK+
Terminals
EM08-T1
EM08-T2
EM08-T16
EM08-T19
EM08-T21
EM08-T22
EM08-T24
EM08-29b
EM08-T31
EM10-T07
EM10-T13
EM10-T25
EM11-T04-a
EM11-T04-b
EM11-T07
EM11-T42
EM11-T50

Target
Sp+
Sp+
SpSpSD+
SD+
Sp+
SDSD+
LD+
SDSo+
SD+
SD+
SDSpSp+

ENK
Contact
AS
AS
AS
AS
AS
S
AS
Apposition
Apposition
Apposition
AS
Apposition
S
Apposition
Apposition
S
AS

NET
Contact
S
S
Apposition
S
S
S
Apposition
S
Apposition
Apposition
Apposition
S
Apposition
S
S
S
Apposition

Note: +: ENK labeled; -: unlabeled; So: soma; LD:
large caliber dendrite (diameter ≥1μm); SD: small
caliber dendrite (diameter <1μm); Sp: spine; S:
symmetrical synapse; AS: asymmetrical synapse.
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5.5 DISCUSSION
This is the first investigation to study the ultrastructural localization of ENK in
the BLa and also the first investigation to study the possible convergence of NET and
ENK axon terminals onto common structures in the BLa. Our results show a limited
convergence.
5.5.1 ANATOMICAL CONSIDERATIONS
ENK axon terminals mainly formed asymmetrical synapses indicating that they
most likely derived from glutamatergic axons, which is consistent with the previous
study showing that more than 95% of ENK+ cells in the BLa expressed vGLUT1 (Poulin
et al., 2008). Since glutamatergic pyramidal cells are the major neuron type in the BLa
(McDonald, 1992), it is possible that some of ENK+ terminals forming asymmetrical
synapses are coming from local collateral axons of pyramidal cells. Additionally, the BLa
is one of the amygdaloid divisions that send ENK projections to the central amygdala,
indicating that at least some of the projection neurons in the BLa express ENK (Poulin et
al., 2006). Another possible origin of these ENK+ terminals are extra glutamate inputs
from thalamus and cortex. Very few ENK+ axon terminals formed symmetrical synapses,
characteristic of GABAergic synapses. These terminals may belong to BLa interneurons
or neurons of the intercalated nucleus, since BLa neurons are under the inhibitory control
of the intercalated neurons and there are extensive colocalization of preproenkephalin
mRNA and GAD mRNA in the intercalated nuclei (Royer et al., 1999, Poulin et al.,
2008) .
ENK+ terminals predominantly formed asymmetrical synapses with ENK+ spines
and distal dendrites, but formed symmetrical synapses with dendritic spines as well. This
synaptic organization is similar to the inputs to pyramidal cell observed before in the BLa
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(Brinley-Reed et al., 1995), indicating that ENK terminals mainly synapse on pyramidal
cells, which give rise to most of the spines in the BLa (McDonald, 1992).
ENK-ir was also found in various postsynaptic neuronal structures, including
somata, axons, dendritic shafts and spines. ENK-ir was also seen in spiny dendrites in the
striatum, which is thought probably to be related to spine plasticity (McCollum et al.,
2012). The function of ENK located in postsynaptic compartment of BLa neurons and
striatal neurons is not clear.
We found very limited convergence of ENK and NET terminals in the BLa. The
extent of convergence may be underestimated due to incomplete terminal analysis. The
convergence will be missed if the observing plane is not favor for analyzing convergence.
5.5.2 FUNCTIONAL IMPLICATIONS
Our observations reveal that ENK terminals predominantly form synapses with
distal dendrites and spines, which probably originate from pyramidal cell in the BLa.
Interestingly, MOR activation has been reported to participate in determining the normal
morphology and function of spines in the hippocampus, which could also occur in the
amygdala as well through the abundant synaptic contacts of ENK terminals with spines
(Liao et al., 2005). Moreover, distal dendrites and spines of pyramidal cells are also the
major neuronal compartment of BLa neurons receiving glutamatergic inputs from cortex,
thalamus and other nuclei of amygdala and are also targeted by neuromodulatory systems
(LeDoux et al., 1991, Stefanacci et al., 1992, Brinley-Reed et al., 1995, Muller et al.,
2011, Zhang et al., 2013), indicating that the ENK could involve in the modulation of
these inputs.
Although we observed very limited convergence between ENK and NET
terminals, if these converging ENK and NET terminals are activated simultaneously, they
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could act concomitantly on the neuronal activity of targeted BLa neurons. Nevertheless,
the low rate of convergence suggests that postsynaptic interaction may not the major way
that these two systems affect each other, at least not by point to point interaction.
Moreover, considering that ENK as a peptide neurotransmitter could diffuse in the
extracellular space and act on distant targets by volume transmission, it is also possible
that ENK could possibly affect NE terminals in this way.
Opioid receptors and adrenoceptors are both G protein coupled receptor; their
activation triggers a cascade of cell signaling response. If they are closely colocalized in
neuronal profiles, they may affect each other via the interactions of the cell signaling
pathways. Earlier studies suggested that MOR and DOR may colocalize with α2
adrenoceptor in a subpopulation of neurons in central and posterior portion of the medial
amygdala, which may relate to the alleviation of opiate withdrawal symptoms by α2
adrenergic agonist (Freedman and Aghajanian, 1985). Farb reported that β adrenoceptors
are present in the somata, dendritic shafts and spines in the lateral amygdala neurons
(Farb et al., 2010). Our findings in chapter 4 indicate that MORs also exist in various
postsynaptic compartment in the BLa. Because of the similarity of cell type and
synaptology between lateral and basolateral amygdala, it is possible that MOR and β
adrenoceptors might colocalize in the BLa as well, which provide an opportunity of two
receptors affecting each other through cell signaling pathway.
There were five cases of ENK+ terminals directly contacting NET+ terminals.
Although previous investigations revealed that MOR activation inhibits NE release in the
BLa (Introini-Collison et al., 1995), this very low rate of direct contact indicates that
there are few, if any ENK+ axon terminals affecting NET release. However, ENK maybe
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released into extra-synaptic space and then diffuse to the NET terminals. Thus it will be
interesting to see whether there is expressing of MOR or DOR on the NET terminals.
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CHAPTER 6
GENERAL DISCUSSION

6.1 SUMMARY
In general, we have the following major findings in these studies. First, about half
of NET+ axon terminals form synapses in the BLa and the major targets of these
terminals were distal dendritic shafts and spines of pyramidal cells. The low synaptic
incidence indicates that non-synaptic diffusion might be involved in NE modulation of
BLa functions. The fact that NE inputs target the same neuronal compartment as
glutamatergic projections to the BLa indicates a possible involvement of NE in long term
potentiation, which is the cellular mechanism of memory potentiation. Second, MOR-ir
was found in various neuronal profiles and the most frequent labeled structures were
small caliber dendrites and terminals. Both symmetrical and asymmetrical synapses were
formed by MOR+ terminals, while the asymmetrical ones were more commonly
observed. The postsynaptic targets of MOR+ terminals included a variety of labeled or
unlabeled neuronal profiles as well, but MOR+ terminals primarily targeted spines with
or without MOR-ir, as well as MOR+ small distal dendrites. These data suggest that
MOR is involved in both presynaptic and postsynaptic modulation of neuronal activity in
the BLa. Third, there was very limited (11%) convergence between ENK+ and NET+
terminals. In addition, our results also reveal that ENK+ axon terminals mainly form
asymmetrical synapses in the BLa, indicating that most of ENK+ terminals might be
glutamatergic.
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6.2 FUNCTIONAL IMPLICATION RELATED TO MEMORY CONSOLIDATION
DURING STRESS
Extensive evidence indicates that the amygdala is a key center mediating the
modulatory effects of hormones and neurotransmitters on memory consolidation, which
selectively occur in the BLa nucleus, the focus of this dissertation (Roozendaal et al.,
2009). The interactions of several modulatory systems converge in influencing NE and
muscarinic cholinergic activations in the BLa and therefore modulate the memory
consolidation in the BLa and other brain areas that receive projections from the BLa
(McGaugh, 2004).
The BLa receives a dense noradrenergic projection primarily originating from the
LC (Asan, 1998). LC neurons fire in two distinct activity modes: tonic and phasic. LC
neurons exhibit phasic responses to salient sensory stimuli such as foot shock, which
have a relatively short latency (Berridge and Waterhouse, 2003). Most of the behavioral
paradigms using acute stressful or emotional stimuli might elicit the phasic response,
whereas the chronic stress model might highly relate to tonic responses. The synaptic
formations we observed in the present study probably contribute to the NE release during
phasic mode, whereas volume transmission might be more involved in regulating the
tonic activity of LC neurons.
We found that distal dendritic shafts and spines of pyramidal cells are the major
postsynaptic targets of NE inputs in the BLa, which is also the main target of excitatory
inputs to CaMK+ pyramidal cells arising from cortical, thalamic and intra-amygdalar
sources (LeDoux et al., 1991, Stefanacci et al., 1992, Brinley-Reed et al., 1995). In
addition, previous studies in rat BLa have shown that both pyramidal cells and

87

nonpyramidal cells exhibit high levels of NMDA receptor subunit1 (NMDAR1) in their
dendrites and spines (Farb et al., 1995, Radley et al., 2007). Thus, NE inputs are in a
position to modulate synaptic plasticity in synapses forming by these various projections
via modulating NMDAR currents. Moreover, we found that small distal dendrites were
commonly labeled by MOR+ and many of them exhibited spines, a characteristic of
pyramidal cell dendrites. Since 85% of BLa neurons are pyramidal cells (McDonald,
1992), this suggests that most of the MOR+ dendrites might belong to pyramidal cells in
the BLa. Therefore, MOR is in a position to affect synaptic plasticity like NE inputs
probably via eliciting membrane hyperpolarization. In addition, our ENK labeling results
reveal that most of ENK axon terminals form asymmetrical synapses in the BLa
indicating they most likely are derived from glutamatergic axons, which might come in
part from local collateral axons of pyramidal cells, or inputs from thalamus and cortex.
These extra amygdala inputs have been found to primarily target the distal dendritic part
of pyramidal cells where the MOR was located according to our results. Thus, ENK
released from glutamatergic inputs to pyramidal cells may activate MORs in pyramidal
cells.
Large numbers of MOR+ terminals indicate that MOR is highly involved in the
presynaptic regulation of the BLa as well. These MOR+ terminals commonly formed
asymmetrical synapses and primarily targeted spines, which are characteristics of
glutamatergic projections to the BLa from cortical, thalamus and other nuclei of
amygdala (LeDoux et al., 1991, Stefanacci et al., 1992, Brinley-Reed et al., 1995) as
mentioned above. Therefore, it is highly possible that MORs may be involved in
modulation of glutamate release in the BLa. Some of the MOR+ terminals forming
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symmetrical synapses might be NE terminals, since NE inputs mainly formed
symmetrical synapses in the BLa as our results have shown (Zhang et al., 2013). This
might explain the effect of opioid peptidergic drug administration on NE release in the
amygdala (Quirarte et al., 1998) , which is believed to be that major way that opioids are
involved in memory modulation during stress (Introini-Collison et al., 1995, McGaugh,
2004).
Previous studies have concentrated on examining the presynaptic interactions of
the ENK and NE systems. Our studies of convergence were designed to investigate their
postsynaptic interactions. We found a limited convergence between ENK+ and NET+
terminals and in most cases of convergence, ENK+ formed asymmetrical synapses or
appositions whereas NET+ terminals formed symmetrical synapses. It appears that
postsynaptic interaction may not be the major way that these two systems affect each
other, at least not by point to point interactions. Because ENK as a peptide
neurotransmitter that could diffuse in the extracellular space and act on distant targets by
volume transmission, it is possible that ENK could affect NE terminals in this way.
Especially, our results show a relatively diverse distribution of MOR in the BLa that
could be activated by ENK.
Except for regulating the plasticity inside the amygdala, NE system activation in
the BLa could also be involved in memory consolidation in other brain areas. For
example, the caudate-putamen is related to learning specific cues while the hippocampus
is associated with spatial learning and context conditioning (Packard et al., 1994, Packard
and Teather, 1998). Both types of learning in both areas are modulated by the BLa
(Packard et al., 1994, Packard and Teather, 1998) . The BLa is thought to influence their
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functions via the extensive efferents arising from BLa pyramidal cells, which are the
major projection neurons in the BLa. Thus the excitability of BLa pyramidal cells is
critical for memory consolidation. β-adrenoceptors have been shown to mediate both the
memory consolidation effects and the excitatory effects of NE in the BLa (Gean et al.,
1992, Huang et al., 1996, Ferry et al., 1997). On the contrary, α2-adrenoceptors seems to
produce inhibitory effects. The two kinds of synapses we observed in our NET labeling
studies, i.e., symmetrical and asymmetrical synapses, might represent the different
adrenoceptors.
Interestingly, only small populations of pyramidal cells were excited by NE in the
BLa via β-adrenoceptors (Buffalari and Grace, 2007). Moreover, an earlier study
suggested that memory facilitation effects of post-training systemic administration of
naloxone might be mediated via release of the beta-adrenergic effects from the tonic
inhibitory influence of endogenous opioids (Izquierdo and Graudenz, 1980). We
observed a very limited convergence between ENK + and NET+ terminals. It is possible
that the small population of the BLa neurons excited by NE are receiving the converging
ENK inputs and thus under inhibitory control of enkephalin, whereas the naloxone blocks
the MOR activation and thus terminate the inhibitory effects of ENK inputs, therefore
BLa neurons were excited by NE via β-adrenoceptors activation.
6.3 FUNCTIONAL IMPLICATION RELATED TO HYPOALGESIA
We also found that some MOR+ axon terminals form symmetrical synapses,
indicating they may come from interneurons. Previous study has shown that activation of
presynaptic MOR could attenuate GABAergic inputs to the central amygdala projecting
pyramidal neurons in the BLA (Finnegan et al., 2006) . This pyramidal cell disinhibition
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might contribute to stress associated hypoalgesia through the BLA-central amygdalaPAG pathway.
6.4 FUNCTIONAL IMPLICATION RELATED TO PTSD
The NE system and opioid system mainly affect pyramidal cells in the BLa
according to our results, which was summarized in Figure 6.1. NE, ENK and MOR
labeled terminals predominantly synapse with the distal small caliber dendritic shafts and
spines in the BLa, indicating that they are at the position that could regulate the effects of
specific input and thus might differentially modulate memory consolidation about
information from different sources in the BLa. This might explain why the PTSD patients
remember certain significant cues during traumatic experiences and later on this trauma
related cue becomes a trigger for maladaptive defensive behaviors in those patients. One
promising direction for PTSD treatment is pharmacologically intervention initiated soon
after trauma exposure, which could reduce or eliminate the development of the PTSD in
some traumatized individuals (Lindgren et al., 2013) (Cukor et al., 2009). The βadrenoceptor antagonist propranolol has been found to decrease the strength of newly
acquired emotional memory both in experimental trials and clinical samples
(Chamberlain et al., 2006) (Lindgren et al., 2013). Moreover, the acute administration of
morphine has been found to limit fear conditioning in patients with traumatic injury
(Bryant et al., 2009). Similarly, another study in combat injury also reported that
morphine used during early trauma care could reduce the subsequent development of
PTSD (Holbrook et al., 2010). This early stage intervention might function through
blocking the facilitation of synaptic plasticity in the synapses formed by salient sensory
inputs. As a result, this intervention might change the emotional valence of these salient
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stimuli and therefore prevent the enhancement of the related memory. Moreover, the
individual differences at this step might contribute to the individual differences in
susceptibility for PTSD.
In addition, NE and ENK both target the somata and proximal large caliber
dendrites of pyramidal neurons in some cases in the BLa. This suggests that they could
directly control the firing of the BLa pyramidal cells and therefore affect synaptic
plasticity in other brain areas receiving projections from them. Thus, the output pathway
of these pyramidal cells is critical for determining what kind of memory is enhanced. It
has been reported that stress and anxiety can enhance dorsal striatal-dependent habit
memory but impede the hippocampal-dependent cognitive memory, which explains some
aspects of PTSD (Goodman et al., 2012) . During robust emotional arousal, BLA
activation leads to memory modulation which impairs the hippocampal dependent
memory processes, resulting in a reliance on dorsal striatum dependent habit memory
(Packard and Wingard, 2004, Wingard and Packard, 2008, Packard and Gabriele, 2009).
Therefore NE and ENK could be involved in this process by affecting the excitability of
certain pyramidal cell populations which connect with either hippocampal or striatal
structures.
Based on our results, these two systems appear to have opposite effects on the
BLa neuronal activity since NET+ terminals mainly form symmetrical synapses and
ENK+ terminals mainly form asymmetrical synapses in the BLa, which has been
supported by previous electrophysiological and behavioral studies (McGaugh, 2004) .
But, how these two systems affect each other is very complex. There is very limited
synaptic convergence of NET and ENK inputs onto the same neuronal target in the BLa.
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But these two systems show potentials for volume transmission: only half of the NET
terminals form synapses and extrasynaptic adrenoceptors have been found in the
amygdala (Farb et al., 2010, Zhang et al., 2013) ; ENK as a neuropeptide could diffuse
for a long distance and reach extra-synaptic receptors, especially considering the widely
spread distribution of MOR we found in chapter 4. Therefore, it is highly possible that
these two systems could interact with each other even without convergence. The opioid
system might serve as a tonic inhibitory control over the NE system. The appropriate
memory modulation may involve a delicate balance of these two systems as well as their
interactions with other neuromodulatory systems. To figure out the exact mechanism, we
need more information about precise localization of their receptors and their
morphological relationship with each other and other neuromodulatory systems in the
BLa.
6.5 FUTURE DIRECTIONS
Our results suggest a complicated interaction between opioid and NE system,
which includes both pre- and post-synaptic effects. Since both synapses and volume
transmission affect NE functions, the localization of specific adrenoceptors and their
morphological relationships to opioid receptors and inputs is critical to understanding
how the NE system affects BLa neuron activity. It would be interesting to explore these
relationships using Immunogold silver staining. Our results also suggest that ENK and
MOR might locate in glutamatergic inputs to the BLa. Therefore it would be interesting
to utilize PHAL tracing technique and immunohistochemistry for ENK or MOR to see
the origin of these ENK or MOR contained glutamatergic inputs.
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Figure 6.1 Schematic diagram of synaptology of NE and opioid system with pyramidal
cells in the BLa. NET+ terminals (Red) mainly form symmetrical synapses with distal
dendritic shafts and spines; ENK+ terminals (Yellow) mainly form asymmetrical
synapses (containing postsynaptic density) with distal dendritic shafts and spines. Both
ENK+ and ENK+ also contact with somata and proximal dendrites of BLa Neurons.
There are limited convergences (black circle) of ENK+ and NET+ terminals onto either
distal dendritic shafts or spines. MORs (black stars) are mainly present on terminals,
distal dendritic shafts and spines. Terminals containing MOR (Black) mainly form
asymmetrical synapses (containing postsynaptic density) with MOR+ (black star) or
unlabeled spines as well as MOR+ (black star) distal dendritic shafts. The BLa affects
synaptic plasticity in other brain areas via its projection to those areas.
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